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Chapter 1 
INI'RODUCTION 
~ Iransition-state analog theory 
Collision theory calculates the probability for formation of an 
activated chemical state using ordinary statistical mechanics. This 
probability for formation of an activated state multiplied by the rate 
of decomposition gives the rate of a chemical reaction (Eyring, 1935). 
The theory need not consider the size or the geometrical shape of the 
colliding molecules. A more sophisticated treatment to the structure-
reactivity relationship in chemical reaction rate is given in the 
transition state theory. The two salient differences of this theory from 
the "collision theory" are that the way in which the reactants collide 
is totally ignored, and only two physical states considered are the 
ground state and the most activated-state on the reaction pathway. In 
this dissertation the combination of the transition state theory and 
knowledge of mechanism of protease catalysis will result in development 
of a powerful technical tool, an affinity chromatography ligand for the 
selective purification of proteolytic enzymes. 
Originally Pauling (1948) proposed that an enzyme has a 
configuration complimentary to the substrate in its activated state, and 
as a result will have higher affinity to the substrate's activated state 
(transition state) than to its ground state. This prediction of higher 
1 
2 
affinity for the transition state comes from a straight forward 
argument made from the scheme depicted in Fig.1. A unimolecular 
conversion of a reactant, S, to a product, P, will occur by the reaction 
pathway with the lowest energy barrier. The structure of the highest 
energy on this lowest energy pathway is designated the transition state, 
sf'. 
The top of Figure 1 shows the reaction of the substrate, S, 
reacting to product, P, in a reaction not catalyzed by enzyme, E. The 
bottom of the Figure-1 shows the same reaction catalyzed by enzyme, E, 
through transition state, ES#. Accordingly Ks is the equilibrium 
constant for association of substrate with the enzyme; K#N and K#E, the 
equilibrium constants for formation of the nonenzymic and enzymic 
transition states, s# and ES#, respectively; and KT the equilibrium 
association constant for association of the substrate in its transition 
state configuration to the enzyme. Based on the definitions for the 
respective equilibrium constants in Fig-1, it is easily shown that they 
are related by equation-1. 
= ( 1) 
In the transition state chemical bonds are in the process of being 
made and broken. The rate at which the transition state decomposes is 
the same as the vibrational frequency v of the bond which is being 
broken. The rate of reaction is therefore obtained from the transition 
E + S 
ES 
Jd'N ~==:!' E + s' 
< I(l 
E 
E + p 
E + p 
Figure 1: Thermodynamic schematic representation of the 
''Transition-state Theory" as applied to enzymatic 
catal ys i~. See text for detail. 
3 
state theory (Lienhard, 1973) by multiplying the concentration of the 
transition state by the rate constant for decomposition. Based on a 
derivation from quantum theory (E:hv) and classical physics (E:kT) the 
first order rate equation will be as shown by equation-2. 
d(P) kT 
-- = -(S/1) 
dt h 
kT 
: -KII N(S) = kn(S) 
h 
(2) 
L: 
where kn is the first order rate constant for non-enzymic reaction, k 
the Boltzman constant, T, the absolute temperature and h the Plank's 
constant. A similar equation can be written for ke and K11 or ES11 in the 
enzymic pathway. Combining equations (1) and (2) gives equation (3). 
= (3) 
where ke/kn is the ratio of the first order rate constant for the 
enzymic and non-enzymic reaction. It is commonly believed that the ratio 
ke/kn is at least 108 (Schultz and Cherva, 1975). Transition state 
theory gives no information about the extent of similarity in structure 
between the transition state of the non-enzymic reaction, sll, and the 
substrate portion of the transition state of the enzymic reaction. 
However, regardless of the extent of similarity, equation (3) may be 
valid (Lienhard, 197 3). 
Equation (3) indicates that the equilibrium association constant 
5 
ror binding of the transition state s# to the enzyme, KT, will be at 
least 8 orders of magnitude larger than the association constant for the 
binding of substrate itself, K8• Generally the value 10
8 is not 
observed, but many examples have been shown of a higher affinity for 
transition-state analogs to an enzyme active site than for an enzyme's 
substrates (Table-1) (Lienhard, 1973; Wolfenden, 1972; Wolfenden, 1976; 
Schray and Klinman, 1974; Lindquist, 1975). 
The purification of proteolytic enzymes from complex biological 
systems is often difficult, especially when the concentration of the 
enzyme is low and multiple enzymes with an identical primary binding 
site specificity are present. Pancreatic proteases were the first 
proteinases purified in the late 20's and 30's by Sumner and Howell. The 
major method of purification was by fractional crystallization. In these 
cases the starting protease had to be present in concentrations from 
milligram to gram quantities. Current conventional chromatographic 
techniques primarily utilize the principals of gel filtration and ion-
exchange chromatography. These methods are non-specific and tedious. A 
more specific form for the purification of proteases is affinity 
chromatography. The ligands used in affinity resins for protease 
purification are general inhibitors, cofactors or substrate analogs. 
More recently antibodies to a particular protease enzyme have been 
successfully employed in purification of proteases. In many cases the 
small inhibitors or substrate analogs do not have high binding 
constants or high selectivity with the protease.In dilute solutions of 
enzyme, the concentration of enzyme is often too low to bind in 
Table 1 
CCJWARISON OF PROPOSED TRANSITION STATE ANAI..(X; INHIDITON CONSTANTS (K ) wmt 
RESPECTIVE SUBSTRATE MICHAELIS CONSTANTS (~) TO SELECTED HYDROLASE ERZIMES 
Enzyme 
Lysozyme 
-Glucosidase (yeast) 
-Glucosidase (yeast) 
Carboxypeptidase-A 
Elastase 
Papain 
Subtilisin 
Amidase 
W.P. Kennedy. 1980. 
Inhibitor, KI, or Substrate, ~. M 
(N-acetylgalactoseamine)4-lacton5, 3x1o-7 (N-acetylgalactoseamine)4, 1x10- 102 
1-aminoglucoside, 2.3x10-6 
p-nitrophenyl-glucoside, 1.4x1or4 1o2 
1-aminogalactoside, 1.6x1or4 
p-nitrophenyl-galactoside, 1.7x1o-2 1o2 
L-benzylsuccinat~, 4.5x1or7 
Cbz-L-Phe, 8x10"'" 
N-Acetyl-Pro-Ala-Pro-alaninal, 8x1o-7 
N-Acetyl-Pro-Ala-Pro-AlaOMe, 1.5x1o-3 
N-Acetyl-Phe-Glycinal, 4.6x1g-8 
N-Acetyl-Phe-GlyOMe, 3.2x10"'" 
Benzeneboronic acid, 8x1Qr4 
N-Acetyl-TyrOEt, 9.0x1~ 
Acetaldehyde-NH~, a .6x1o-5 
Acetamide, 8.3xTO"'" 
considerable yield. Antibodies have been used as ligands to alleviate 
the problem of low binding constant. However, antibodies are difficult 
to produce. More importantly, often severe conditions are required to 
dissociate the protease from the antibody, which may result in the 
irreversible denaturation of the protease (Scouten, 1974). 
~ peptide aldehydes ~ ligand in affinity resins. 
In the case of the serine proteases, the mechanism of substrate 
catalysis has been shown to go through an acylserine intermediate (ES') 
in a scheme depicted by equation 4; where ES is the Michaelis complex, 
k2 the first order rate constant for formation of the acylserine 
intermediate from ES, k3 the pseudo first order rate constant for 
hydrolysis of the acylserine intermediate, P1 the first product of the 
reaction (amine or alcohol), and P2 the second (acid) product of the 
reaction (Bender and Kezdy, 1964; Henderson, 1970). 
(4) 
A non-covalent intermediate is formed first between substrate and 
enzyme followed by the attack of the hydroxyl of the serine active site 
on the substrate to give an acylserine intermediate, releasing the amine 
or alcohol (step k2). The acylenzyme is then hydrolyzed to form the 
enzyme and second product (step k3). The transition state configuration 
for the hydrolyzable peptide (or ester) carbonyl carbon in steps k2 and 
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k3 is thought to be tetrahedral (sp3) (see fig-3) (Kraut, 1969; Roburtus 
~ a1., 1972). X-ray crystallographic studies of the enzyme-substrate 
binding complex of various polypeptides to subtilisin BPN' using a 
difference-Fourier method and model building experiments suggest that 
the carbonyl carbon assumes a tetrahedral conformation in the transition 
state, as this results in more favourable contacts between the 
substrate specificity residue P1 and the enzyme. The enzyme active site 
can form four hydrogen bonds to stabilize the transition-state and 
thereby lower the free energy of activation for reaction (Robertus ~ 
a1u 1972). In addition, structural data indicate the binding of leaving 
I groups at P1 and hydrogen bonds to the carbonyl group of the scissile 
bond, are better oriented when the carbonyl carbon becomes tetrahedral 
(Blow ~ ~ 1974). Accordingly, substrate analogs that place the 
proper charge distribution and stereochemistry around the carbonyl 
carbon, that is an sp3 configuration in the catalytic site, may mimic 
features of the transition state configuration and will be expected to 
associate with extremely high affinity (Wolfenden, 1969). 
Peptidyl aldehyde substrate analogs may present an sp3 C-1 
configuration to the active site of protease enzymes when associated as 
the hydrated adduct IB or as a covalent hemiacetal IIA or IIB (Fig.2), 
and thus may be predicted to associate with high affinity as a 
transition state analog. In agreement with the prediction, it has been 
found that specifically designed natural and synthetic peptide aldehydes 
associate 102 to 104 times better to serine proteases than their 
analogous substrates (Kennedy and Schultz, 1979; Aoyagi and Umezawa, 
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Figure 2. Scheme for association of peptide aldehyde with the active 
site of SERINE proteases: IA and IB are Michaelis complexs with the C-1 
carbonyl carbon of the aldehyde in spf and sp3 configurations, 
respectively; IIA and IIB are hemiacetal adducts with the active site 
Ser-195 of the enzyme. In the hemiacetal adducts IIA and IIB the C-1 
carbonyl carbon of the aldehyde also has a sp3 configuration as in the 
transition state of the substrate reactions catalysed the protease 
enzyme. 
1975; Thompson, 1973; Westerick and Wolfenden, 1972; Frankfater and 
KuppY, 1 981 ) • 
1() 
In future discussions the nomenclature introduced by Schechter and 
Burger (1967) will be used as follows: the substrates are lined up with 
the enzyme in such a way that the hydrolyzing CO-NH group occupies 
the catalytic site; the amino acid residues of the substrate each occupy 
adjacent subsites in the enzyme, those towards the NH2-terminal occupy 
subsites s1, S2, s3, etc., those towards the COOH-terminal of the 
' ' ' substrate occupy subsites S 1, S 2, S 3 etc of the enzyme. The positions 
' ' of the residues in the substrates are numbered P1, P2,P3 or P 1, P 2' 
p'3 according to the subsites they occupy. 
Umezawa initiated the study of peptide aldehydes with the 
discovery of the leupeptins from Actinomycetes culture medium. The 
leupeptins are inhibitors of trypsin-like (proteases specific to 
arginine or lysine in the primary binding site, P1) proteases (Aoyagi ~ 
~ 1969). These inhibitors were shown to be peptide aldehydes in which 
the carboxylic group is reduced to an aldehydic group. These were the 
first examples of peptide aldehyde competitive inhibitors of serine 
proteases. Aldehyde inhibitors are turned over by protease enzymes in a 
similar way to normal substrates (Kennedy and Schultz, 1979). They 
reversibly form an acyl serine type adduct, which decomposes to a 
product that is the same as starting substrate (Kennedy and 
Schultz,1979). This assures a constant concentration of the peptide 
aldehyde inhibitor in solutions of inhibitor and enzyme. If a peptide 
aldehyde is used as a ligand in affinity resin it may therefore be 
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expected that this resin could bind serine proteases effectively by 
forming a reversible covalent adduct with the protease of high affinity. 
Many interesting serine proteases such as these involved in thrombolytic 
and fibrinolytic processes have a primary specificity for arginine. 
Argininal affinity resin should bind these serine proteases containing a 
primary site (P1) specificity for arginine. 
Currently utilized protease affinity resins for arginine specific 
proteases utilize ligands such as benzamidine and lysine with binding 
constants to protease enzymes of 5x1o-4 M to 1x1o-2 M (Holmberg ~ ~ 
1976). In contrast the peptidyl aldehyde ligands have affinity constant 
2 to 7 orders of magnitudes higher than these commonly utilized ligands. 
Because of the higher affinity of the peptidyl aldehyde ligand, dilute 
proteases may be purified with significantly higher yields. 
Investigations on the secondary specificity of trypsin-like 
proteases show that variation of the amino acid sequence 
N-terminal to the P1 residue in the substrate can lead to the ability 
of a substrate to be hydrolyzed selectively by a particular plasma 
protease within a group of plasma proteases. Accordingly, the peptide 
p--nitroanilide H-D-Phe-Pro-Arg-pNA is selective substrate of thrombin. 
It may be suggested that D-Phe-Pro-Argal would be a selective inhibitor 
of thrombin (Bajusz ~ ~' 1978). While the benzamidine and lysine 
sepharoses do not show any dramatic specificity or selectivity between 
different plasma proteases with trypsin-like specificity, the selective 
affinity of the peptidyl aldehydes can be used for the purification of 
an individual specific protease within a biological pathway. Thus X-Y-
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Argininal affinity resins can be designed for the purification of a 
particular protease among a group of proteases with a primary site 
specificity towards arginine. 
~ ~ Q( ~ Dissertation 
The major objective of my research is to exploit the thermodynamic 
predictions of the transition-state theory for the practical purpose 
of protease purification utilizing highly selective and specific 
peptidyl aldehydes. The application of this technique will have a 
general usefulness in the isolation and purification of biologically 
important proteases. In this Disertation I will: 
(1) Synthesize tripeptidyl aldehyde ligand affinity resins of the 
general formula R-X-Y-Argininal where R- is the resin matrix and 
X-Y is a dipeptide. Methods are developed to bind and dissociate 
protease enzymes to these resins and selectively separate a particular 
trypsin-like protease. 
(2) Show progress towards development of a develop general procedure 
for the purification of proteases in which the substrate of the protease 
is attached by its N-terminal residue to an inert support, treated with 
a biological solution containing the protease activity to be purified, 
. and the COOH-terminal of the peptide fragment chemically modified to a 
peptidyl aldehyde to generate the transition state analog inhibitor of 
the protease of interest. This affinity resin is evaluated for the 
selective purification of the protease that was used to generate the 
acid ligand product. By this procedure, an unknown protease can be 
purified from complex biological systems based solely on the 
availability of its substrate. 
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In this research the examples of thrombin and urokinase are used to 
demonstrate what I view as general procedures of protease purification. 
It is hoped that establishing of the general procedure will allow other 
workers to utilize these techniques in their own work, with their 
protease of interest. 
Chapter 2 
REVIEW OF THE RELATED LITERATURE 
~ Protease purification and mechanism Q( action Q( serine proteases. 
The mechanism of action for enzymes was proposed even before it was 
known that enzymes are proteins. For example important kinetic studies 
on cell free extracts of enzymes were carried out by Buchne in 1897. It 
wasn't until 1935 that the first enzyme was crystallized by Northrop and 
Kunitz, producing enough pure enzyme to prove that the enzymes were 
proteins (Northrop and Kunitz, 1939). Purification by crystallization is 
useful only when the protease is present in large quantity. When the 
quantity of enzyme is low and the matrix from which the protease is to 
be purified is complex, chromatographic techniques become essential. For 
the purification of bovine pancreatic trypsin, Chao (1965) used eM-
cellulose in citrate buffer at pH 4.8. Three years later Schroder (1968) 
used sulfonyl Sephadex to separate five different active forms of 
trypsin. In the last twenty five years, since its introduction by Porath 
(1959), gel-filtration has occupied a key position in the purification 
of hundreds of enzymes. A comprehensive review of literature on the use 
of gel-filtration and ion-exchange chromatographic techniques by various 
researchers is beyond the scope of this dissertation. 
Serine proteases are a class of proteases containing a uniquely 
reactive serine residue that is primarily responsible for their 
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catalytic activity. A general criterion of the serine proteases class is 
that they react irreversibly with organophosphates such as diisopropyl 
fluorophosphate (Jansen, 1949) with complete loss of its proteolytic 
activity. The pH maxima of most extracellular serine proteases is around 
7.8 with a group of pKa = 6.8 controlling activity. Modification studies 
using N-tosyl-L-phenylalanine chloromethyl ketone by Schollmann and Shaw 
(1963) indicated that the group of pKa 6.8 is a histidine. The X-ray 
studies (Blow and Steiz, 1970) showed that His-57 (chymotrypsin 
numbering) is within H-bonding distance of the active site serine-195. A 
third important group shown by X-ray crystallography studies to be 
present at the active site of serine proteases is belived to be an 
aspartic acid residue (Asp-102). 
By early 1960's utilizing innovative kinetic and analytical 
techniques, the basic features of the mechanism of action of serine 
proteases on amide and ester substrates was elucidated (Bender ~ ~ 
1964; Zerner and Bender, 1964; Kezdy fi.s.l....., 1964; He conn fi.s..l..., 1971; 
Fersht, 1971; Fastrez ~ ~ 1971; Mackenzi, ~ ~ 1984; Nakagawa and 
Umeyama, 1984). The details of the evidences in support of the mechanism 
have been thoroughly reviewed (Bender and Kezdy, 1965). The accepted 
reaction sequence for serine proteases is as shown in Fig.3 (Kraut, 
1977). 
The initial step in the reaction pathway is the formation of a 
reversible non-covalent intermediate (the Michaelis complex) with 
dissociation constant, Ks, between substrate and protease. In a second 
step, nucleophilic attack at the substrate scissile carbonyl carbon by 
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R-K-x + E-OH 
Ks R-g_X:E-OH k1 
o-
:lao R-6-o-E < < 
x··-ir+ k_, 
~HX 
2 g 
R-C-0-E 
~ 
R-g_Y + E-OH ~~ R-g_Y:E-OH 
_ k3 HY 
R-f.iE 
k4 
Figure-3. The reaction sequence for serine proteases. 
(Kraut, 1977). 
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an active site serineJ'OH residue results in the formation of an acyl-
enzyme intermediate concomitant with the release of an alcohol or amine 
product. In the third step (step k3), water acts as the nucleophile in 
the hydrolysis of the acyl enzyme intermediate, regenerating the free 
enzyme and releasing the acid product. 
The focal point of the future discussion will be the carbonyl 
carbon <c1) of the substrate undergoing hydrolysis. As we shall see 
there is considerable evidence for the occurrence of a tetrahedral 
intermediate in serine protease-catalyzed hydrolysis. Earlier it was 
shown that non-enzymatic acyl substitution reactions with carbon-oxygen 
fission generally occur through the formation of an acyl-nucleophile 
adduct in which the carbonyl carbon assumes a tetrahedral configuration 
(Bender, 1960). From the kinetic study of chymotrypsin catalyzed 
hydrolysis of p-nitrophenyl thiolacetate and p-nitroanilide, Frankfater 
and Kezdy suggested of necessitating the existence of an intermediate in 
which the carbonyl carbon most likely to assume a tetrahedral 
configuration (Frankfater and Kezdy, 1969). It was also suggested by 
Caplow (1969) that the carbonyl carbon of the substrate assumes sp3 
configuration in proposed transition state similar in structure to the 
putative tetrahedral intermediate, during formation of acyl enzyme 
intermediate. X-ray crystallography with difference-fourier calculations 
and model building to the active site also suggest that the carbonyl 
carbon assumes a tetrahedral configuration (Kraut, 1977; Robertus, 
1972). X-ray diffraction studies at high resolution, 1.8 A0 , of 
Streptomyces griseus with a peptide aldehyde also showed the existence 
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of tetrahedral conformation for the aldehyde in the active site, 
supporting the stability of the sp3 conformation in substrate hydrolysis 
(James .tl. .aJ......, 1 980). 
In addition to the X-ray crystallography, spectrophotometric 
techniques such as laser Raman spectroscopy and 13c NMR has provided 
evidence for formation of tetrahedral conformation. Hess and Seybert 
(1975) using chymotrypsin and phenylethane boronic acid with laser Raman 
spectroscopy showed a band at 684 cm-1 present in the spectra of the 
crystalline enzyme inhibitor complex, which indicates a tetrahedral 
configuration for the boronic acid in the enzyme. Additional evidence 
for formation of a tetrahedral intermediate in protease enzymes with 
transition-state analog inhibitors will be reviewed in the transition 
state analog section. 
~ Inhibitors Q[ Serine Proteases 
The knowledge of the primary specificity for a protease in its 
hydrolysis of peptide bonds provides the starting point for the 
development of substrate related synthetic inhibitors. Specificity is 
primarily determined by the side chain of the amino acid contributing 
the carbonyl function to the bond to be split. Chymotrypsin requires an 
aromatic or bulky nonpolar side chain, in r 1 while trypsin requires a 
lysine or arginine residue in P1• X-ray studies have shown that these 
different substrate specificities arise from structural changes in the 
enzyme binding site. In trypsin-like proteases, one residue in the 
binding pocket is an aspartate. This aspartate can form a strong 
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electrostatic bond with a positively charged lysine or arginine side 
chain of a substrate. Accordingly non-substrate compounds that similarly 
contain a positively charged group, either amidinium or guanidinium will 
be expected to bind preferentially trypsin-like proteases at the active 
site and hence act as competitive inhibitors. Thus Guia and Shaw (1965) 
showed that benzamidine, p-aminobenzamidine, phenylguanidine, 
cyclohexylcarboxamidine, cyclohexylguanidine, 2-phenylacetamidine and 
acetamidine are competitive inhibitors of trypsin (Table 2). 
Benzamidine and p-aminobenzamidine were the first examples of the 
most potent small molecular competitive inhibitors of trypsin. They are 
approximately the same size as the side chain of lysine or arginine. 
Many other compounds with a positively charged group and a hydrophobic 
moiety have also been found to possess an inhibitory effect. These are 
alkyl and aryl guanidines, amidine and agmatine derivatives, benzoyl and 
tosyl arginine, aliphatic and aromatic amines, and p- or w-amino 
carboxylic acids (Keil, 1971). The reversible binding property of these 
small inhibitors have been exploited to map the spatial arrangements at 
the specificity site of the proteases. Table-3 shows the Ki values of 
variety of low molecular weight compounds containing guanidine group for 
thrombin (Geratz and Tidwell, 1977). From the data it is evident that 
the ring system other than benzene achieve an even tighter fit with the 
enzyme, most likely due to improved hydrophobic interaction. The 
introduction of a pyruvic acid group in the ~ position to the amino 
side chain augmented the inhibitory activity not only in thrombin but 
also with plasmin, trypsin and enterokinase (Geratz and Tidwell, 1977). 
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Table 2 
Competitive inhibitors of trypsin at pH 8.15 and 15 °C 
Inhibitor 
8.25x1<r6 
1.8x1o-5 
7.25x1o-5 
1.51x1o-2 
1.511x1o-3 
Guia and Shaw (1965) 
Table-3 
Thrombin inhibitors restricted to the 
specificity pocket of the enzyme 
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---------------------------------------------------------------Compound Structure 
---------------------------------------------------------------
Benzyl amine 
Phenylguanidine 
Benzamidine 
p-Aminophenyl-
pyruvic acid 
,S-Napthamidine 
5-Amidinoindole 
12.3x1o-3 
HN -<0) ~C-NH 0 H N/ 2 
2.2x1o-4 
6.5x1o-6 
8.5x1o-5 
·--------------------------------------------------------------
Geraz ~t ,al., ( 1977). 
Initially the development of more active inhibitors directed towards 
trypsin-like proteases beyond primary specificity pocket was chiefly a 
empirical process. It consisted of the attachment of a number of 
different side chains to the starter compound which in most cases were 
represented by benzamidine. The substituents chosen were aliphatic, 
aromatic, arylaliphatic, bicyclic or heterocyclic in nature. 
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Even though substituted benzamidines can differentiate between two 
different enzymes from different specificity classes, like chymotrypsin 
and trypsin, they will fail to differentiate the enzymes in the same 
class, for example between thrombin and trypsin. Rather than an 
empirical process for designing low molecular weight inhibitors, the use 
of small peptides and peptide derivatives is more logical. To obtain 
additional direct information about the binding sites of proteases 
outside of the primary binding site, reactive polypeptide inhibitors 
were designed. For example Schollmann and Shaw (1962) in developing 
chloromethyl ketone inhibitors combined N-tosyl-L-Phe to confer affinity 
to the primary active center and halomethyl ketone grouping to achieve 
irreversible alkylation of active site histidine. It was predicted that 
the increasing the peptide length to dipeptide and tripeptides can lead 
to higher specificity. Morihara and Oak (1970) showed that on 
incubation of two different chloromethyl ketone derivatives of peptide 
substrates, CBZ-L-Ala-L-Phe and CBZ-L-Ala-Gly-L-Phe with subtilisin, a 
much higher rate of inactivation of the enzyme was observed compared to 
chloromethyl ketone of CBZ-L-Phe. During the same period Powers and 
Wilcox (1970) reported the synthesis of specific peptide chloromethyl 
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ketones for chymotrypsin and showed an inhibition of crystal growth. 
Thompson and Blout (1973) also showed that three different peptide 
chloromethyl ketones differ markedly in their ability to inactivate the 
elastase with the longer peptides reacting more rapidly. Thompson and 
Blout (1970) reported large increase in the esterase, amidase and 
peptidase activities of elastase 4x106 fold on increasing the length of 
peptide substrate from one to five amino acids N-terminal from the 
scissile bond. Too much increase in the length of the peptide also could 
be counter productive in case of inappropriate folding of the peptide. 
Table 4 shows binding constants of natural and synthetic peptides to 
thrombin. Scheraga ( 1977), and Blomback ll. .al..... ( 1977) have shown that 
I 
while large segments of the residues P16 through P 35 of the fibrinogen 
are required for high peptidase activity by thrombin, the equilibrium 
binding constants (Km or Ks) for small peptide segments or synthetic 
peptide analogs of fibrinopeptide-A may be as good or better than that 
for the natural substrate fibrinogen (Table-4). From the binding 
constants it could be seen that small peptides up to penta peptide 
inhibitors bind better than its natural substrate and CNBr digestion 
products. 
Plasma proteases involved in coagulation processes and fibrinolytic 
processes like thrombin, urokinase, kallikrein etc. have a primary 
· specificity for arginine, and are therefore grouped in the class of 
trypsin-like proteases. Investigations on the secondary site 
specificities of these trypsin-like proteases show that oligopeptide 
substrates having the appropriate amino acid sequence N-terminal to the 
Table 4 
Binding constants of natural and 
synthetic polypeptides to thrombin 
Polypeptide 
Fibrinogen (natural substrate) 
CNBr-A( ) (human)c 
CNBr-B( ) (bovine)d 
1.2x1cr5a, 3x1o-6b 
4.7x1cr5 
1.9x1o-4 
Synthetic peptide chloromethylketones:e 
Gly-Val-ArgCH2Cl 
Val-Pro-ArgCH2Cl 
Phe-Ala-ArgCH2Cl 
Phe-Ala-LysCH2Cl 
H-D-Pro-Phe-Arg-OH 
1 .3x1cr5 
6.7x1cr7 
2.9x1o-6 
3.7x1o-5 
1x10-6 
a At pH-9 from K in which rate of fibrinogen cgnversion to 
fibrin followed ~y light scattering technique. At pH-7.4 
from Km in which rate of fibrin conversion followed by 
appearance of fibrinopeptiges by R.I.A. c Residues 1 through 
51 in fibrinogen A-chain. Residues 1 through 115 in 
fibrinogen B-chain. e Determined from Ks in the study of 
rates of thrombin modification by chloromethylketones. 
Richard M. Schultz N.I.H grant application (HL24910). 
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residue could be selectively hydrolyzed by a particular plasma 
protease within a mixture of related enzymes (Fareed ~ ~ 1981; 
Cleason and Aurell, 1981). Table-5 shows specific activity of various 
plasma proteases against various synthetic chromogenic substrates. 
Because these are trypsin-like proteases, the presence of either 
arginine or lysine in the P1 position is essential for primary 
specificity. Variation of the amino acid sequence of residues in 
positions P2 through P4 in small peptide substrates leads to the ability 
to selectively react with one of the plasma proteases in the presence of 
other trypsin-like plasma proteases. 
The design of small peptide inhibitors thus relies on the knowledge 
of the required amino acid sequence around the scissile bond (Kettner ~ 
~ 1980). Hegeman and Scheraga studied the sequence around the Arg-Gly 
bond in fibrinogen hydrolysis by thrombin to define the required 
structural elements for the optimum thrombin-fibrinogen interaction. 
Blomback ~ ~ (1977) also independently came to a common conclusion 
that amino acids 1 to 51 in A chain contain all the necessary elements 
for optimal interaction. To construct a 51 amino acid residue long 
peptide inhibitor could be a very difficult task. The approach taken by 
Thompson and Blout (1973b) seems to be a more practical approach. They 
synthesized a number of peptide amides for elastase mimicing the natural 
substrate elastin, and measured kinetic parameters for the elastase 
catalyzed hydrolysis of dipeptides to pentapeptides. By comparing Ki 
values they identified s3 as the subsite unable to bind proline. The 
contributions from subsites s5 to s2 towards interaction between enzyme 
Table 5 
Relative activities of trypsin-like proteases towards different substrates 
----
-P:rP2-P1-- Relative activity of the enzyme 
----------
Thrombin Factor Xa Plasma Glandular Plasmin Urokinase 
Kallikrein Kallikrein 
Bz-Phe-Val-Arg-pNA 0.1lt0 0.002 0.004 0.001 0.002 0.001 
Bz-Ile-Glu-Gly-Arg-pNA 0.005 0.200 0.005 0.003 o.otli 0.007 
D-Phe-Pip-Arg-pNA 0.480 0.008 0.007 0.004 0.002 0.002 
D-Val-Leu-Lys-pNA 0.002 0.001 0.007 0.020 O.OitO 0.000 
D-Val-Leu-Arg-pNA 0.005 0.001 0.006 0.130 0.002 0.001 
D-Pro-Phe-Arg-pNA 0.030 O.OitO 0.190 0.100 0.040 o.ooo 
~lu-Gly-Arg-pNA 0.620 0.003 0.004 0.001 0.001 0.001 0.040 
A.B Kabi, Blood product divjsion, Sweden. 
, 
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and substrate was shown to be sufficient for practical purposes, and 
interactions beyond s5 could be safely ignored for the design of a 
peptide inhibitor. In case of thrombin-fibrinogen system, important 
contribution to binding are made by residues relatively far from the 
scissile bond within the structure such as the Phe in P9 and Asp in P10 
positions. When the substrate is folded in a helical structure, the 
ninth position N-terminal becomes close to the s3 position (Marsh ~ 
~ 1982; 1983). Accordingly, the peptide aldehyde H-D-Phe-Pro-Argal in 
which a hydrophobic residue at position 3 in a D conformation, is found 
to be able to mimic the Phe in position 9 of the normal substrate and to 
be a selective and potent tripeptide inhibitor of thrombin (Bajusz ~ 
~ 1978). This peptide inhibitor is thus designed on the basis of one 
of the products of thrombin hydrolysis, namely the N-terminal segment of 
substrate (P2 in eq. 4). 
Design of the peptide inhibitors based on a substrate which 
spans the active site on both directions i.e. N-terminal and C-terminal 
of the scissile bond, have also been investigated (Szelke ~ ~ 1982). 
A strategy involved in designing these inhibitors is to reduce the 
succeptible amide bond to the -CH2-NH- moiety. Since the protease can 
not hydrolyze -CH2-NH- bond, the peptide inhibitor is termed as non-
hydrolyzable isosteric peptide inhibitor. For example a number of such 
inhibitors for renin are synthesized by Szelke ~ ~ (1982). The 
inhibitor designed in this way H-Pro-His-Pro-Phe-His-Leu-R-Val-Ile-His-
Lys-OH is 30,000 times more active than the human octapeptide from which 
it was derived. It is argued that the greatly enhanced renin inhibitory 
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activity of angiotensinogen analog bearing a reduced peptide bond is due 
to the change of a configuration at the scissile bond. The -CH2-NH-
moiety is isosteric with the tetrahedral transition state formed during 
amide hydrolysis and is therefore bound to the enzyme more tightly than 
the substrate. It is further argued that because transition state 
isosters bind to the enzyme so much more tightly, the effect of 
structural variations present in substrates of different species is 
magnified, resulting in the large difference in binding to human 
compared with dog renin (Szelke n_ .sl....., 1982). 
A potential transition state analog for serine proteases could 
be designed by considering the charge distribution and stereochemistry 
around C-1 of an inhibitor which should give a resemblance to the 
proposed tetrahedral transition-state. The peptide acids generated by 
protease catalyzed hydrolysis of proteins are generally good inhibitors 
of the enzyme that produced them, but the analog which mimics relevant 
features of the transition state complex will form an even stronger 
complex with the enzyme. A species I (fig-4) similar to transition state 
in step-2 of fig-3, has been proposed by Jencks (1969) and Thompson 
(1973) to be intermediate in the hydrolysis reaction catalyzed by 
several proteolytic enzymes, e.g. the serine and cysteine proteases. 
This suggests that the functional group which will provide tetrahedral 
geometry and suitable charge distribution upon binding to the protease's 
active site is expected to be a strong inhibitor for serine and cysteine 
proteases. 
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OH OH 
I I 
R-C-0-Enzyme 
I 
R-B-0-Enzyme 
I 
NR'R" OH 
I II 
OH OH 
I I 
R-C-0-Enzyme 
I 
R-C-S-Enzyme 
I 
H H 
III IV 
Figure-4. Tetrahedral intermediates of 
serine and cysteine proteases. 
(See text for detail) 
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~ Transition ~ analogs Q( serine ~ cysteine proteases 
Initially alkyl boronic acids, which readily form tetrahedral 
addition compounds, Fig. ~, were proposed as transition state analogs 
for chymotrypsin (Koehler and Lienhard, 1971). The use of boronic acid 
group as an inhibitor, that binds strongly but yet could be removed 
easily by a slight change in pH, was initiated by Berezin. 
The tetrahedral intermediate will be highly unstable by virtue of 
good leaving groups on the carbonyl carbon. It will collapse easily to 
give either the acyl enzyme or the substrate. In case of alkyl boronic 
acid as a substrate, the ionized alkyl boronic acid (species II in fig-
4) will be relatively stable. The support to this argument comes from 
the experimental observation that the benzene boronic acid (K1:1.96x10-~ 
M) associates stronger to chymotrypsin than to its substrate analog, 
benzyl alcohol <Kr= 1.0x10-2M). X-ray crystallography of benzene boronic 
acid-subtilisin complex the showed formation of a tetrahedral structure 
for benzene boronic acid, which formed a covalent bond between boron and 
alcoholic oxygen of serine residue of subtilisin (Mathews, 1975). 
Spectrophotometric determinations revealed a two step mechanism, in 
which a fast bimolecular association process is followed by a slower 
unimolecular isomerization process representing covalent bond formation 
(Nakatani tl .a.L_, 1977 ). 
X-ray crystallography of the complex formed between subtilisin and 
L-Phe-L-Ala-L-Lys chloromethyl ketone at 2.5 A0 showed that it also 
formed a stable hemiacetal in which carbonyl carbon atom was 
tetrahedrally coordinated (Poulous fi .al...., 1976; Robertus fi .al...., 1972). 
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x-ray investigation at 2.8A0 of the binding of papain to some peptide 
chloromethyl ketone inhibitors, containing L-Phenylalanine at P2 
provided informative structural data about enzyme substrate interaction. 
Electron density difference maps of the papain-inhibitor complex 
revealed that the carbonyl oxygen of the P1 residue is near two 
potential hydrogen donating groups in the active site of the enzyme. The 
carbonyl oxygen of the P1 residue, carrying a formal negative charge in 
the tetrahedral intermediate, may be stabilized by formation of two 
hydrogen bonds with the backbone NH of cysteine-25 and the NH2-group of 
glutamine-19 (Drenth, 1976). Thus the c1 carbonyl carbon of peptide 
halomethyl ketones, upon associating with serine and cysteine proteases, 
appears to assume a tetrahedral structure in its stable inhibitor 
complex. Since these polypeptide halomethyl ketones inactivate serine 
and cysteine proteases by alkylating an active site histidine, the 
binding is irreversible and the utility of these inhibitors as ligands 
in affinity chromatography for purification of proteases is non-
practical. This leaves alkyl boronic acids or peptide aldehydes as 
possible alternatives for ligands in affinity chromatography. 
It is clear that derivatives of peptide acids in which the 
carboxylic acid group has been replaced by an aldehydic group are more 
potent inhibitors of certain proteases than are the original acids. This 
phenomenon was first discovered by Kawamura and Umezawa (1969) while 
screening filtrates of Actinomycetes for naturally occurring protease 
inhibitors. It was also independently discovered by Westerick and 
Wolfenden (1972) and by Thompson (1973) in a search for transition state 
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analogs for cysteine and serine proteases. Aldehydes are unique among 
carbonyl carbon in preferring to exist as tetrahedral addition 
complexes. The hemiacetal (species III) is relatively stable. There are 
clear analogies between the tetrahedral species I, II and IV. 
Hemiacetals and hemithioacetals might therefore be expected to be good 
transition state analogs for those proteases which react through a 
tetrahedral intermediate or transition-state of general structure I. 
These hemiacetals or hemithioacetals should be easily generated from the 
corresponding aldehyde and the enzyme. 
It is of interest to find out whether aldehydes are bound by 
enzymes as covalent adducts or not. Alternatively inhibition could be by 
a non-covalently associated aldehyde hydrate. Using a cross-saturation 
technique in nuclear magnetic resonance spectroscopy, Bendall ~ ~ 
(1977) provided the first direct evidence for formation of 
hemithioacetal, formed from the aldehyde and the active-site thiol group 
in papain. It was also shown that the aldehyde, and not the hydrated 
form, is the true inhibitor. Lewis and Wolfenden (1977) made use of 
effect of deuterium substitution on the equilibrium addition of 
nucleophiles to aldehydes to discriminate between noncovalent and 
covalent associations of aldehydes to papain. The secondary isotope 
effects on Ki can theoretically distinquish between covalent and 
noncovalent binding of aldehyde. The results suggested a thiohemiacetal 
is formed at the active site, indicating a covalent binding. 
Because of the strong nucleophilic character of the active site 
serine residue in serine proteases, formation of a stable covalent 
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complex between the enzyme and the aldehyde was considered to be very 
likelY (Thompson, 1973). Since the formation of aldehyde hydrates and 
hemiacetals are subject to general-base catalysis, the His-residue in 
the active site may, a priori be expected to facilitate formation of 
a hemiacetal by removal of a proton from the serine. Aldehydes exist 
predominantly as hydrates in aqueous solution. The hydrates, which are 
gemdiols, can bind to proteases non-covalently. However, it was not 
thought that the hydrate would have a high affinity even though they 
present a tetrahedral c1 carbon to the enzyme as Ac-Pro-Ala-Pro-Alaninal 
binds 1000 times stronger than Ac-Pro-Ala-Pro-Alaninol to elastase at 
pH-7.0 (Thompson, 1973). Since it was believed that the non-covalent 
binding of the aldehyde hydrate could not strongly bind to elastase, 
Thompson (1973) suggested that it is not the hydrate but the unhydrated 
form of the aldehyde that binds to the enzyme. 
Additional evidence to support binding of the free aldehyde and not 
the hydrate also comes from NMR. A plot of the corrected line-width of 
the CH proton of the aldehyde and the hydrated aldehyde for the 
chymotrypsin-inhibitor (Bz-Pheal) rati~ at pD 6.5 showed that the 
aldehyde and not the hydrated aldehyde is in equilibrium with the 
inhibitor on the enzyme (Chen ~ ~ 1979). In 19F NMR spectra of DL-
Ac-Pheal there are two signals assigned to the aldehyde. The smaller 
signal at -37.6 ppm is assigned to the free aldehyde and the larger 
signal at -38.4 ppm to the hydrate. Upon addition of chymotrypsin, two 
new signals appeared at -33.8 and -37.1 ppm. The percentage of the total 
19F signal area corresponding to the -33.8 ppm signal increases with 
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increasing E/I ratios. Concomitantly the free aldehyde signal at -37.6 
ppm decreases dramatically in intensity relative to the hydrate signal, 
leading to the same conclusion reached before by Chen ~ ~ (Gorenstein 
and Shah, 1 982 ). 
As the unhydrated aldehyde is the species that is primarily 
associated, the true Kr for aldehyde association is equal to 
Kr(obs)/(1+Kh), where Kh is the hydration association constant in water. 
Although 1 M formaldehyde irreversibly denatures thrombin, simple 
aldehydes such as formaldehyde and acetaldehyde have no effect at 
micromolar concentration. This suggests that the inhibition of peptidyl 
aldehydes are unlikely to be a non-specific reaction of the aldehyde 
with the enzyme (Westerik and Wolfenden, 1974). 
The support for association for the aldehyde analog to chymotrypsin 
as a hemiacetal (IIA or IIB in fig 2) comes from the observation of 
association of aldehyde analog of the.nonspecific substrate 
hydrocinamide to chymotrypsin by a cross-saturation NMR technique (Low 
and Nurse, 1977). This was further supported by similar double resonance 
experiments but with specific substrate analog, Bz-Pheal, with 
chymotrypsin (Chen ~ ~ 1979). The chemical shifts of hemiacetal are 
most clearly defined under conditions of slow exchange on the NMR time 
scale with the bound aldehyde (EI), which is known from the observed 
line broadening to be in fast exchange with the free aldehyde. In the 
case of the chymotrypsin and Ac-Pheal, maximum cross-saturation is 
observed at the chemical shift of 5.36 ppm. This is the region in which 
maximum cross-saturation is expected to be observed for the proton of 
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the hemiacetal formed between the aldehyde and the active site serine 
residue of chymotrypsin. The chemical shifts and signal line widths for 
all protons of both Ac-Pheal and Bz-Pheal are essentially unaffected by 
added (methyl-histidinyl-57)- chymotrypsin. The lack of clear evidences 
for chemical exchange or cross-saturation in (methyl-histidinyl-57)-
chymotrypsin is due to tighter binding of aldehyde to the enzyme and 
hence a slower dissociation rate which will fall within the NMR slow 
exchange limit (Chen ~ .al.,., 1979). 
Cross-saturation NMR studies of N-trifluoroacetyl-L-Ala-L-Pheal 
with chymotrypsin showed broadening of free aldehyde resonance upon 
addition of chymotrypsin (Gorenstein and Shah, 1982). The detailed 
analysis identified the enzyme bound hemiacetal as the species which was 
in slow exchange with the free aldehyde. From the line broadening 
dependency with pD, it is suggested that a single group on the free 
enzyme (pKa=7.9) control the appearance of an alkaline form of the 
hemiacetal (Wyeth ~ ~ 1980). Fluorine NMR spectra of N-Ac-DL-p-
fluoro-Pheal in the presence of chymotrypsin showed separate signals for 
the hemiacetal complex, the bound aldehyde along with the free aldehyde, 
and the free hydrate (Gorenstein and Shah, 1982; Shah and Gorenstein, 
1983). 
The pH dependency of Ki(obs) for Bz-Pheal binding to native 
chymotrypsin between pH-3 and pH-8 exhibit a lack of a significant pH-
dependency. This lack of pH dependency suggests that the basic form of 
charge relay system, which probably participates in the transition state 
of substrate catalysis (Kraut, 1977), is not required for the high 
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affinity of the aldehyde Bz-Pheal to chymotrypsin. This result correlates 
with the high affinity observed for Bz-Pheal to (methyl-histidinyl-57)-
chymotrypsin, in which the charge-relay system is modified by 
methylation of His-57 instead of protonation at pH<7 (Kennedy and 
Schultz, 1979). Chen ~ .sL.. (1979) also found a poor affinity between 
Bz-Pheal and (dehydroalaninyl-195)-chymotrypsin by proflavin 
displacement. This is because of the lack of ability of Ser-195 to form 
covalent hemiacetal adduct between Bz-Pheal and Ser-195. In addition 
the observation that the alcohol derivative (Bz-Pheol), which contains 
an sp3 configuration about its C-1 carbon and thus can only associate 
non-covalently, does not have a high affinity to native chymotrypsin 
suggests the formation of a covalent hemiacetal adduct for the tightly 
bound aldehyde (Kennedy and Schultz, 1979). 
A reasonable explanation of the pH independence of Ki(obs) for Bz-
Pheal association is that a two proton transfer occurs on Bz-Pheal 
association leading to the protonated tetrahedral complex IIB (Fig.2) 
as the major association species, rather than the anion species IIA. The 
simplest form of reaction sequence between an aldehyde and a serine 
protease could be depicted as in equation 5. 
E + Aldehyde(unhydrated) IA IIA and or IIB •••• (5) k_, 
where IA, IIA and IIB are species shown in fig-2. Step k2 may be 
depicted as a two step proton transfer process in which the His-57 
imidazole first abstracts the proton from the r-0 of serine-195 
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generating the Y-o- nucleophile, and in a second step the solution 
donates a proton to the oxygen anion on C-1 of the aldehyde resulting in 
the capture of the stable neutral tetrahedral adduct IIB. As the reverse 
reaction would be specific base-general acid catalysis and it is 
kinetically indistinguishable from general base catalysis, both k2 and 
k_2 have the formate kx = k(lim)/(1+~/Ka). The denominator term cancels 
out in the ratio k2/k_2 and thus KI(obs) shows no dependency on 
hydrogen ion concentration. The small variation in KI(obs) with pH may 
be simply due to small increases in Ks with decreasing pH. 
Alternatively, a two proton transfer can occur in a concerted 
rather than in a stepwise fashion. In a concerted process the His-57 in 
step k2 acts both to abstract the -OH proton from the serine and 
simultaneously donate that proton to the developing oxygen anion of 
incipient IIA, generating IIB in a single step. In any case, both steps 
k2 and k_2 require the basic form of the His-57, and the ratio k2/k_2 
and thus KI(obs) show no clear pH dependency (Kennedy and Schultz, 
1979). 
James ~ ~ (1980) described a structure of the microbial enzyme 
Streptomyces griseus protease-A in its native conformation at 1.8 A0 , 
and in complexes with Ac-Pro-Ala-Pro-Phe-OH, Ac-Pro-Ala-Pro-Try-OH and 
Ac-Pro-Ala-Pro-Pheal, at pH 4.1. The resultant electron density maps 
showed that the peptide aldehyde forms a covalent hemiacetal bond with 
Ser-195. The distance from the carbonyl carbon of the aldehyde to the l(-
0 of Ser-195 being 1.73 A0 • The corresponding distances in the protease-
peptide complexes are 2.58 A0 and 2.66 °A, and continuous electron 
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density from d(-o to the carbonyl carbon atom of the peptides is absent. 
Papain, a cysteine protease has similarities in mechanism to serine 
proteases in association of peptide aldehydes. Aldehydes, structurally 
related to the acyl portion of the substrates, are extremely potent 
competitive inhibitors of papain at pH- 5.5 and 25° C, approximately 1 
mole of acetyl-L-phenylalanyl amino acetaldehyde binds per mole of 
papain, with Ki:4.6*1o-8M (Westerik and Wolfenden, 1972). Also it is 
shown that aldehydes protect the enzyme against inactivation by N-
ethylmalemide. It is clear that the aldehydes form stable 
thiohemiacetals which are similar to the hemiacetals formed in serine 
proteases. 
Thus the reaction of aldehydes with papain occurs in two steps as 
shown in equation 6 (Mattis rt .ala., 1977), 
E + A EA' ••••••••• ( 6) 
where EA is the Michaelis complex and EA' is suggested to be a covalent, 
tetrahedral hemithioacetal with the cysteine-25 sulfhydryl. Frankfater 
and Kuppy (1981) studied the association of Ac-Phe-Glycinal with papain 
in the pH range 3.5-9.5 at 25° C using intrinsic papain fluorescence to 
measure aldehyde binding. The limiting values of Ki and the second 
order association rate constant k2/Ks, corrected for hydration of Ac-
Phe-Glycinal in solution, are 9.05x1o-1° Hand 4.95x107 H-1s-1, 
respectively. The solvent deuterium isotope effect on the rate of 
association is 0.77, indicative of the participation of the thiolate-
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imidazolium ion pair. The mechanism of aldehyde association shown in 
fig. 5 with papain is proposed. Since it is likely the structure IV is 
the predominant form of the hemiacetal in solution, a proton transfer 
must occur in subsequent steps following formation of the Michaelis 
complex. The value of <3 for the pKa of His-159 in papain-aldehyde 
adduct may reflect a direct interaction between the N-1 of His-159 and 
the hydroxyl group of the hemithioacetal. It is argued that the 
hemithioacetal may be about 103 times more stable in papain than in 
solution. The wide range and diagnostic power of 13c NMR made possible 
signal assignments for the aldehyde inhibitor-papain complex. Two 
distinct hemithioacetal forms were observed which can be titrated 
separately, one of which is more stable than the other at pH 7.0. They 
appear to be equal amounts of both distereoisomers formed by the 
creation of the new assymetric carbon generated on hemithioacetal 
formation. One diastereoisomer bound in a nonproductive mode is in 
rapid equilibrium with the Michaelis complex (ES) while the other 
distereoisomer in a productive mode is in slow equilibrium with the 
Michaelis complex (ES) (see Fig. 6) (Gamcsik .tl £1.....,, 1983). 
Thus the formation of a covalent hemiacetal or hemithioacetal 
adduct between a peptide aldehyde and serine or cysteine protease is 
supported by various techniques such as stopped-flow spectrophotometry, 
proton NMR, 13c NMR, fluorine NMR, and X-ray crystallography. 
2DL Peptide aldehydes ~ inhibitors Q( proteases 
As it was noted previously, Umezawa initiated the study of peptide 
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I 
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II III IV 
Figurt--5. Formation of hemithioacetal by addition of 
the Cys-25 thiolate of the Papain to the 
aldehyde carbonyl of peptide aldehyde 
inhibitors. 
Aldehyde 
R-CH 0 ~ R-CH(OH)2 
+E1l Hydrate 
Tt:, ~ 
~~RE ~~RI{ 
OH H 
~ ~ 
Nonproductive Productive 
~ Oxyanion hole R Hydrophobic pocket 
c His-159 
E = Papain 
Figure-6. Model of association of aldehyde to papain. 
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aldehydes produced by microorganisms as inhibitors of protease enzymes 
in 1965. Since than nearly 50 inhibitors of various mammalian enzymes 
have been identified in microbial culture filtrates. Their structures 
have been elucidated and most of them have been chemically synthesized 
(Umezawa, 1982). Leupeptin, which inhibited plasmin, trypsin, pepsin and 
cathepsin B, was discovered by testing for plasmin inhibiting activity 
in Streptomyces culture filtrates (Aoyagi ~ ~ 1969). Two leupeptins 
were isolated, and their structures were determined to be acetyl or 
propionyl-L-Leu-L-Leu-L-Argal (Kawamura ~ ~ 1969). Later a number of 
other leupeptins were identified which contained L-Ile or L-Val instead 
of L-Leu. NMR studies of leupeptins in aqueous solution indicates that 
most of leupeptin exists as the hydrated and the hydroxypiperidine forms 
(Maeda~~ 1971; Schultz and Kozlowski, unpublished data). While 
leupeptin inhibits trypsin like proteases, it does not inhibit 
chymotrypsin. The aldehyde group in the argininal moiety is an absolute 
requirement for inhibiting activity. If it is oxidized to acid or 
reduced to alcohol, the compound's inhibitory activity disappears. 
Along with leupeptins other important peptide aldehydes of the 
microbial origin are antipain, chymostatin and elastinal. Fig 7 shows 
the chemical structures of these inhibitors. Antipain inhibits papain, 
trypsin, cathepsin B; chymostatin inhibits chymotrypsin like proteases; 
and elastinal inhibits pancreatic elastase. Table 5 shows the inhibition 
constants of leupeptin, elastinal and pepstatin against trypsin, 
elastase and pepsin, respectively. The biosynthetic pathway of the 
leupeptins have been elucidated from Actinomycetes and the three 
NH2 
CH3 ~:;CH3 ~:;cH3 (~~3 !0-NH-rH-CO-NH-!H-CO-NH-C~ID 
LEUPEPTIN 
ANTI PAIN 
/NH, 
1"3 1"2 j=NH ~2 
~H2 fH/ ( H2)3 CH3 CH-CH3 C~ NH t 
H2N-CO-tH-NH-CO-NH-tH-CO-NH- H-CO-NH-!H-CID 
ELASTINAL 
Figure 7. Cheffi cal structures of protease-inhibitors 
of m crobial origin. 
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Table 6 
Kinetic constants of endopeptidase inhibitors 
------
Inhibitor 
Leupeptin 
Elastinal 
Peps tat in 
Enzyme Substrate 
Trypsin TAME 
BAEE 
Elastase Ac-(Ala)~NA 
Pepsin Phe-Gly-His-Phe 
(N02)-Phe-Ala Phe-ME 
Umezawa ~ Ql., (1983). 
~ Kr Type of 
(x10lJ M) (x107 M) inhibition 
7.1 3.lJ Competitive 
4.8 1.3 Competitive 
3.2 2.4 Competitive 
0.4 0.001 Competitive 
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important enzymes of the pathway have been isolated. These enzymes are 
leucine acetyl transferase, leupeptin acid synthetase, and leupeptin 
acid reductase. The membrane bound leupeptin acid reductase requires ATP 
and NADH (Umezawa, 1983). 
Even though the physiological function of leupeptins and other 
inhibitors of microbial origin is not clearly known, the possible use of 
these inhibitors as therapeutic agents has received considerable 
attention. In addition, these enzyme inhibitors could be useful in the 
analysis of biological functions and disease processes. Biological 
activities of leupeptins have been investigated by Aoyagi ~ ~ 
(1969). Oral administration of leupeptin exhibited an anti-inflammatory 
effect in edema. Leupeptin also inhibited coagulation in humans and 
rabbits, but not in dogs and rats. These inhibitors are relatively non 
toxic (Libby and Goldberg, 1978; Sher ~ ~ 1981). Intra-venous 
injection of 250 mg/kg and intraperitoneal injection of 1000 mg/kg of 
antipain caused no deaths in mice. In the case of leupeptin, HD50 to 
rats and rabbits are as follows: rats 125 mg/kg by intravenous 
injection, >4000 mg/kg by subcutaneous injection and oral 
administration; rabbits 35mg/kg by intravenous injection, 300mg/kg 
subcutaneous injections, >1500 mg/kg by oral administration (Aoyagi ~ 
~ 1969). The use of leupeptin as possible therapeutic agent in 
muscular dystrophy, cancer metastasis and number of other diseases have 
been investigated in animal models (Umezawa,1983; Umezawa,1979). The 
exceptionally good inhibition constants of these microbial peptide 
inhibitors have generated a good amount of interest for use in the 
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inhibition of the important physiological proteases. 
Specificity toward a particular enzyme may be obtained by varying 
amino acid sequence in P2, P3 and P4 position of inhibitors in a C-
terminal aldehydic peptide similar in structure to the naturally 
occurring peptide aldehydes. A number of peptide aldehydes targeted 
toward specific enzymes have been synthesized and tested for their 
inhibitory properties. Galpin ~ ~ (1984) synthesized protease 
inhibitors with the general structure Z-Arg-X-Pheal where X= Leu, Ile or 
Val. These compounds showed strong inhibitory activity towards 
chymotrypsin whereas the semicarbazide derivatives of the compounds and 
showed considerably reduced activity. Renin catalyzes hydrolytic release 
of angiotensin I from the N-terminal end of angiotensinogen. From prior 
knowledge of the amino acid sequence around the scissile bond in 
Szelke's (1982) experiments on angiotensinogen, Kokub ~ ~ (1984) 
postulated that small peptides of the angiotensin I sequence with 
leucinal at its C-terminal might inhibit renin. Three different 
compounds were synthesized and the results obtained show that these 
aldehyde compounds are highly selective and species specific inhibitors 
for human and monkey renins. Fehrenz ~ ~ (1984) synthesized a series 
of tripeptide aldehydes of the type P-A-Y-Xal where P is aoC-NH2 
protecting group, A is an aromatic residue, Xal is either leucinal or 
phenylalaninal and Y is a variable residue. The result showed that these 
peptide aldehydes are also very specific and potent inhibitors of renin. 
Acrosin is an important intracellular endopeptidase of spermatozoa 
that is exposed to the cell surface at the time of gamete fusion. The 
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proteinase assists the penetration of spermatozoon through the outer 
investment of the ovum by proteolytic degradation of the zona pellucida, 
a glycoprotein layer surrounding the oocyte. The presence of natural and 
synthetic acrosin inhibitors effectively prevents zona penetration and 
hence fertilization in yitro and in YiYQ (McRorie and Williams, 1974). 
consequently, synthesis of acrosin directed inhibitors is highly 
desirable in view of their potential contraceptive action. Khatri and 
stammer (1980) synthesized small N-phosphorylated peptide aldehydes 
analogous to both leupeptin and phosphoramidon. As phosphoramiradon is 
an inhibitor of acrolysin, combination of these two structures in to one 
molecule produced a compound inhibitory to both the enzymes. Borin ~ 
~ (1981) synthesized a series of leupeptin analogs R-Lel-Leu-
Argininal with variable N-terminal substituents. These modified 
leupeptins proved to be strong competitive inhibitors of the acrosin 
from mammalian spermatozoa with inhibition constants in the range of 
4.7x1o-7M (R=H) to 9.7x1o-7M (R=t-Boc). Preliminary data in this study 
indicated that Boc-leupeptin and F3Ac-Leupeptin derivatives do not 
exhibit higher toxicity than the leupeptin. 
Specific peptide aldehyde inhibitors have been targeted for a 
number of enzymes involved in coagulation and fibrinolytic processes. In 
case of thrombin, the structure of these inhibitors correspond to the 
thrombin sensitive region of its clotting factor substrates. Bajusz ~ 
al. (1978) synthesized a series of tripeptide aldehydes, X-Pro-Argal and 
X-Val-Argal. The molecular excess of inhibitors to enzyme required for 
doubling the clotting time of fibrinogen in plasma was found to range 
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over five orders of magnitudes, 6.3 times for D-Phe-Pro-Argal to 45950 
times for Gly-Val-Argal. From this observation of D-Phe-Pro-Argal being 
a potent inhibitor of thrombin, Tremoli ~ ~ (1981,1984) showed that 
it significantly prolonged the human whole blood recalcification time in 
~and inxiYQ, as well as plasma thrombin, partial thromboplastin 
and prothrombin times. In vivo experiments showed a 90% reduction in 
experimental thrombosis in rats at 6mglkg intravenous administration. A 
comparison of the inhibiting activity of Boc-0-Phe-Pro-Argal and D-Phe-
Pro-Argal towards thrombin and plasmin indicates that the Boc-
derivative inhibits both plasmin and thrombin while the free peptide 
aldehyde has practically no effect on plasmin (Bajusz ~ ~ 1981). 
~ Affinity chromatography 
Thirty years after its introduction (Lerman, 1953), affinity 
chromatography. (a method of purification based on affinity between two 
molecules) has become a major means for the purification of biologically 
active molecules. The purification of proteins by conventional 
procedures is frequently laborious and incomplete, and the yield are 
often low. Enzyme purification based on a highly specific biological 
property - strong reversible association with specific substrates or 
inhibitors - has received major attention (Cuatrecasa, Wilchek and 
Anfinsen, 1968). Despite the enormous expansion of the field and many 
enzymes that have been purified, the directions for the investigation of 
methods have not changed markedley. The component attached to the solid 
matrix support is called a ligand. The attachment may be made by 
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physical adsorption or by a covalent bond. The covalent attachment is 
rar superior and should be used whenever possible to prevent leakage of 
the ligands. In affinity chromatography of an enzyme, the enzyme to be 
purified is passed through a column containing a crossed linked polymer 
or gel to which a specific inhibitor, cofactor, substrate analog or an 
antibody specific to the enzyme has been covalently attached. All 
proteins, without substantial affinity for the bond ligand will pass 
directly through the column, where as the enzyme that recognizes the 
ligand will be retarded or stay bound, depending upon its affinity 
constant. Elution of the bound enzyme is readily achieved by changing 
such parameters as ionic strength, pH or by addition of a competitive 
inhibitor in the eluting solution. In this dissertation we introduce 
additional method for removing a bound enzyme by reversible chemical 
modification of the ligand thereby, effectively reducing the 
concentration of active ligand (Patel and Schultz,1982; Patel~~ 
1983). 
The success of the technique depends largely on mimicking the 
interaction between the two components that occurs when both compounds 
are in free solution. The successful application of the method requires 
that the adsorbent have a number of favourable characteristics. The 
unsubstituted matrix or gel should show minimal interaction with 
proteins, in general, both before and after coupling to the specific 
binding groups. It also must form a loose, porous network that permit 
easy entry and exit of macromolecules and have favourable flow 
properties. The chemical structure of the support must permit the 
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convenient and extensive attachment of ligands under relatively mild 
conditions, and through chemical bonds that are stable to the conditions 
of adsorption and elution. Finally, the ligand which is critical in the 
interaction must be sufficiently distant from the solid matrix to 
minimize steric interference with the binding process. This could be 
achieved through a spacer arm between ligand and matrix. 
Enzymes represent the largest group of macromolecules purified by 
affinity chromatography. The purification of enzymes by affinity 
chromatography can be divided mainly in to three categories. The first 
category includes ligands designed for the purification of a wide range 
of enzymes by using general ligands like cofactors. The most commonly 
used cofactors are NAD, NADH, ATP and Co-A or their derivatives. The 
second category includes ligands directed at enzymes of narrow 
specificity, i.e. enzymes purified with the aid of specific inhibitors 
or substrates. In this case the specificity is much higher for the 
enzyme for which the column was tailored. At times, specific columns 
serve also for the purification of a family of enzymes having similar 
specificity. e.g. benzamidine-Sepharose for trypsin like proteases. The 
third category includes ligands designed on a knowledge of a part of the 
three dimensional structure of the enzyme to be purified. For this 
method either polyclonal or monoclonal antibodies are used as ligands. 
Unless there is cross-reactivity, these affinity resins are highly 
selective for a particular enzyme. In any case the degree of 
complementarity between interacting molecular surfaces or regions of the 
constituents of a complex determines the magnitude of attraction, and 
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thus the strength of a complex. 
An agarose is the predominant choice as an innert matrix in 
affinity chromatography of enzymes, and cyanogen bromide as an 
activating agent. Fig 8 shows mechanism of activation of Sepharose by 
cNBr and subsequent coupling of the ligand. Detailed analytical data of 
freshly activated Sepharose showed that 60-85% of the resins total 
coupling capacity is due to the formation of the cyanate esters (cyanate 
ester 80%, imidocarbamates 20%) (Kohn, 1981). Once the mechanism of 
activation was established, it opened up new ways to develop more 
efficient activation procedures and these are extensively reviewed by 
Wilcheck ~ ~ (1984). Among these, organic sulfonyl chlorides provide 
a coupling procedure which give a high yield of stable linkages at 
neutral pH. Organic sulfonyl chlorides such as p-toluene sulfonyl 
chloride (tosyl chloride) and 2,2,2-trifluoroethane sulfonyl chloride 
(tresyl chloride), can be used to convert hydroxy groups into good 
leaving group (sulfonates) that, on reaction with nucleophiles, allow 
stable linkages to be formed between the nucleophile and the initial 
hydroxyl group carrying carbon. These reagents appear to be suitable for 
the immobilization of enzymes and affinity ligands to support bearing a 
hydroxyl group, such as agarose, cellulose, glycophase glass and others. 
The activation and coupling of the ligands to the support are though to 
involve the following steps (Nilsson and Mosbach, 1984). 
Activation: 
Support-CH20H + RS02Cl 
Coupling: e.g. NH2- nucleophile 
CNBr ~ ---)~ 0-C::N 
H 
CYNATE ESTER 
(very reactive) 
ISOUREA 
DERIVATIVE 
0 
hydrolysis n ~O-C-NH2 CARBAMATE (inert) 
NH 
interchain ~ o.j 
rearrangement ~0-C-
intrachain ~ 
c-NH 
rearrangement 
N-SUBSTrnrrED 
IMIOOCARBAMATE 
LINEAR 
IMIOOCARBAMATE 
(very slightly reactive) 
CYCLIC 
IMIOOCARBAMATE 
(slightly reactive) 
N-SUBSTITUTED 
CARBAMATE 
Figure-8. Mechanism of activation of Sepharose by CNBr and 
subsequent coupling of ligand. Heavy lines indicate 
major reactton pathways. 
(WUchek .tl. .al_. , 1981!) 
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--~> Support-CH2-NH-ligand. 
The influence of R group on the relative reactivity of sulfonates with 
organic molecules containing hydroxyl groups was found to be 1:100:4000 
with R= -C6H4CH3, -CH2cF3 and -CF3 respectively. Thiols and primary 
amino groups are the most reactive nucleophiles with sulfonate esters on 
gels. Thiols have the highest reactivity. Imidazole and tyrosine 
hydroxyl groups can also displace the esters. This broad range of 
reactive nucleophiles can be a great advantage when a very tight binding 
between protein and support is desire, i.e. for stabilization or 
freezing of the protein conformation. 
Among the synthetic carriers, hydrophylic cross-linked polyacrylic 
polymers are of great interest. The distinct advantages of these 
polymers are the far superior mechanical stability compared to agaroses 
and their innertness to microbial degradation. In addition they have a 
higher stability towards acids, bases and organic solvents. The degree 
of porosity and chemical composition can be achieved by selective co-
polymerization or by chemical modification of preformed polymers. 
Various synthetic polymers based on acryamide or acrylate and their use 
to immobilize enzymes have been reviewed by Mosbach (1977). 
Certain amino acid residues in proteins are amenable to covalent 
.. reaction for immobilization of proteins or peptides on innert supports. 
Table 7 shows eleven amino acids whose residues could be considered 
reactive enough to participate in covalent coupling to a carrier. Of the 
amino acids listed in Table 7, the most frequently used functional 
groups are -NH2, -SH and -COOH. 
-~ 
-SH 
-COOH 
-S-S-
Table 7 
Reactive residues of proteins 
-Amino of Lysine and H-terminus amino group 
Sulfhydryl of cysteine 
Carboxyl of Aspartate and Glutamate 
and C-terminus carboxyl groups 
Phenolic of Tyrosine 
Guanidine of Arginine 
Imidazole of Histidine 
Disulfide of Cysteine 
Indole of Tryptophan 
Thioether of Methionine 
Hydroxyl of Serine and Threonine 
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The most widely used procedure for covalent coupling of proteins to 
a support has been the one devised by Ax en ll. .al....., ( 1967). The 
polysaccharide (Sepharose) is activated with cyanogen bromide and the 
activated sepharose is coupled to an amino group on the protein to yield 
the immobilized product. Currently a number of sepharose derivatives 
with desired spacer arm and appropriate functional group to covalently 
bind to specific ligands are commercially available. The spacer arms 
ranges from four carbon atom to fifteen carbon atoms long, predominantly 
either with amino or carboxylic terminal. The reactive derivatives of 
spacer arm equipped sepharoses are also commercially available. Among 
these derivatives, N-hydroxy succinamide ester activated sepharoses are 
very useful for rapid, high efficiency coupling for all ligands that 
have a primary amino group. 
Affigel-10 and Affigel-15 (Bio Rad) are N-hydroxy succinimide 
esters of a derivatized cross-linked beaded agarose gel support. Both 
couple to ligands containing primary amino group spontaneously in 
aqueous or non-aqueous solutions. Figure 9 shows the chemical structures 
of Affigel-10, Affigel-15, and the coupling reaction of the Affigels 
with the ligand containing a free amino groups. Affigel-10, which 
contains a neutral 10-atom spacer arm, has been used to couple a wide 
.. variety of ligands in affinity chromatography. Affigel-15 contains a 
cationic charge in its 15 atom spacer arm, which significantly enhances 
coupling efficiency for acidic proteins at physiological pH. The N-
hydroxy succinamide active ester method is highly selective for primary 
amino groups of ligands between pH-6.5 to 8.5. Proteins can be coupled 
Affi-Gel 10 
Affi-Gel 15 
1 LJLR-~ _P_H_6_.5_to_a_.5~ 
r ~ buffer 
Figure-9. Coupling reaction of Affi-Gels 10 and 15 with 
ligand containing free amino groups. 
56 
57 
within four hours at 4°C. Since the coupling is through an amide bond 
and the spacer arm is linked through an ether bound to the matrix, an 
excellent resistance to urea, guanidine.HCl, heat, solvents, acids and 
bases (pH 2 to 11) virtually eliminates ligand leakage during storage 
and use (Conn ~ ~ 1981). Both Affigel-10 and Affigel-15 are used 
during this investigation to prepare affinity resins. The exact coupling 
strategy and conditions will be discussed in a later section. 
Initially lysine and benzamidine sepharose affinity resins were 
prepared for purification of trypsin like proteases. A typical procedure 
involved activation of sepharose with CNBr and coupling of either lysine 
or p-amino benzamidine with or without a spacer arm (Hatton and 
Recoeczi, 1976). The solution containing enzyme is charged onto a column 
of benzamidine Sepharose in low ionic strength (50 mM NaCl buffer) and 
subsequently washed with higher ionic strength NaCl-buffer in order to 
wash off nonspecifically bound proteins. Elution of the enzyme is done 
under competitive conditions, i.e. the eluent contains either p-amino 
benzamidine or other protease inhibitor (Anderson ~ ~ 1977). 
In affinity chromatography of trypsin like proteases, the 
positively charged aminidinium or guanidinium group is required for 
primary specificity. These groups must be excluded from the covalent 
bonding of ligand to matrix. In the case of peptidyl aldehydes as 
ligands, the aldehydic group is also essential for the formation of a 
reversible covalent bond with the protease. This leaves only the N-
terminaloC-NH2 group for covalent bonding with the matrix. Since the N-
terminalc(-amino group is acetylated by either acetyl or propionyl group 
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in the leupeptins, in order to use leupeptin as a ligand for affinity 
adsorbents, appropriate modification is required. Ishii and Kasai (1980) 
used thermolysin to hydrolyze the bond between two leucines in leupeptin 
to expose an~amino group. Figure 10 shows the outlines of the 
preparation of the affinity resin. The aldehyde group was protected as 
dibutyl acetal and deprotected after immobilization. As expected, these 
affinity resins showed strong affinity for trypsin-like proteases. In 
addition, the resins completely lost their binding ability, if the 
aldehyde group was converted to the corresponding alcohol by treatment 
with NaBH4• The argininal resin bound enzymes like Streptomyces griseus 
trypsin, plasmin, kallikrein, urokinase and clostripain. Ishii could not 
elute the enzymes by the conventional methods, such as by an elevation 
of ionic strength, lowering of pH, or addition of denaturents. 
Successful elution was achieved only by the addition of 0.02 mM 
leupeptin to the eluting buffer at very slow rate, after incubating 
overnight. The eluted enzyme was not active because it was complexed 
with leupeptin and the activity was only restored after inactivating 
leupeptin by NaBH4 (2mM). To regain enzyme activity it was important 
that the enzyme tolerate such reductive treatment. Nishikata ~ ~ 
(1981) prepared Sepharose-Gly-Gly-Argal, and showed it to be a strong 
affinity resin for bovine trypsin. The enzyme was eluted with 8 M urea 
or 1mM leupeptin in buffer at a flow rate of 6 ml/hr. While tosyl-lysine 
chloromethyl ketone-trypsin and (dehydroalanine-195)-trypsin failed to 
bind the resin, carbamoyl methylated (His-46) trypsin bound to the resin 
and could be eluted with 50mM HC1/1M NaCl. 
1-BuOH 
R 
Leupeptin (I) 
12 .))Bu 
R1-Leu-Leu-NH-CH-CH Leupeptin dibutylacetal 
'oau 
Thermo lysin 
R 12 /OBu 
H-Leu-NH-CH-CH '-
OBu 
Leucylargininal 
dibutyl acetal 
Illloobilization 
R 12 OBu 
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Leu-NH-CH-CH~ 
OBu 
Immobilized leucylargininal 
dibutylacetal 
R 12 H Leu-NH-CH-C~ ~0 Immobilized leucylargininal 
Figure-10. Preparation of affinity resin using 
Leu-Argininal as ligand. 
Ishii~ .a.J..., (1980). 
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Anderson and Wolfenden (1980) have described a technique they named 
"transition state affinity jump" chromatography. In this procedure, a 
double selection method for isolation of active enzyme, a substrate 
analog is used as a ligand and a transition- state analog is placed in 
the solution of eluent. Thus a mixture of native chymotrypsin and 
dehydroalanine-(195)-chymotrypsin was applied to a column containing D-
tryptophan methyl ester as an affinity ligand. While both forms of 
chymotrypsin were retained, catalytically active enzyme selectively 
eluted with the peptide aldehyde chymostatin leaving catalytically 
inactive dehydroalanine-chymotrypsin bound to the column. 
Nishikata (1983) also prepared an affinity resin using Gly-Gly-
Pheal which is a synthetic analog of chymostatin as a transition -state 
analog for chymotrypsin. Bovine chymotrypsin and Streptomyces griseus 
protease B showed strong affinity toward the adsorbent. The dissociation 
constant, Kd, of the enzyme-immobilized ligand complexes were determined 
by frontal gel chromatography. The value of dissociation constants 
varied from 13x10-6M at pH-6.5 to 1.7x10-6M at pH-8.2 for chymotrypsin. 
The author tried to validate the results by comparing the dissociation 
constant obtained with Ac-Val-Val-Pheal at pH 7.7 (3.8x10-6M), and that 
of Ac-Pro-Ala-Pro-Pheal to be 3x1o-6M at pH-8.0, with the argument that 
Ac-Val-Val-Pheal and the ligand Gly-Gly-Pheal have similar structures. 
The difference in size and hydrophobic nature of side chains of glycine 
and valine should be pointed out here, and it could be very significant 
in terms of interaction with the enzyme in s2 and s3 subsites. 
Proposed transition state analogs other than peptide aldehydes also 
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have been used as affinity ligands. Pohl ~ ~ (1984) used Val-D-Leu-
Pro-Phe-Phe-Val-0-Leu as an affinity ligand, which is a transition-state 
analog inhibitor of aspartate proteinases of the pepsin type. The 
affinity adsorbent bound human, porcine and chicken pepsin, human 
gastrin and bovine cathepsin D over the pH range 2 to 5. The elution of 
enzyme was achieved by a low ionic strength buffer at higher pH 
containing 20% dioxane, in yields exceeding 70%. The resin however, 
failed to separate human pepsin from human gastrin. A more specific 
inhibitor like H-77 (0-His-Pro-Phe-His-Leu-R- Leu-Val-Tyr, where R is a 
reduced isosteric bond -CH2-NH-) of acid-proteases, was used as ligand 
for purification of human kidney renin by Mcintire ~ ~ (1983). With 
this affinity adsorbent, human renin was isolated from crude extract of 
kidney cortex with 5500 fold purification and 76% yield. The purified 
enzyme was free of non-specific acid-proteases and was stable at pH 6.8 
and -20°C over a period of several weeks. 
~ Plasminogen activator 
The examples of plasminogen activator and thrombin are selected in 
this dissertation to develop affinity adsorbents. Both of these enzymes 
are trypsin-like proteases and have important roles in fibrinolytic and 
coagulation processes. Both plasminogen activator and thrombin resemble 
trypsin and plasmin in their activities towards synthetic substrates, 
but there are differences in their relative activities which depend upon 
the particular substrate on which they act (Table 4). However, 
62 
plasminogen activator and thrombin are much more selective in their 
specificity toward proteins. There are several different types of 
plasminogen activators, including tissue activator of plasminogen, 
vascular plasminogen activator, blood plasminogen activator and 
urokinase. Tissue activator of plasminogen may be identical or similar 
to blood plasminogen activator, but different from urokinase which is 
isolated from urine or kidney cell cultures. Tissue plasminogen 
activators are serine proteases with a molecular weight of approximately 
66,000 and composed of one polypeptide chain. By limited proteolytic 
action, this one-chain activator is converted in to a two-chain 
activator linked by disulfide bonds. Both the one chain and two chain 
plasminogen activator have similar activity in clot lysing systems, but 
different specificities toward synthetic substrates (Wallen ~ ~ 
1981). Urinary plasminogen activator was described in 1951 by Williams 
and in the following year was named urokinase. There are two forms of 
urokinase, one with Mw=54,000 and a smaller form with Mw=34,000. Both 
high and low molecular weight urokinase behave similarly in an in vitro 
whole blood thrombolytic perfusion system (Greenwald and Chandler, 
1983). It has been shown that urokinase is much more selective than 
plasmin in its action on proteins, plasminogen being the only substrate 
against which urokinase shows activity. Robins ~ ~ (1967) showed 
that during the activation of plasminogen to plasmin, a single bond 
Arg560_Val561 is cleaved by urokinase. 
The mechanism of proteolysis of a single-chain plasminogen molecule 
to two-chain disulfide-linked plasmin molecule by urokinase is by the 
~3 
following steps (Violand and Castellino, 1976; Summaria ~ ~ 1975). 
In the first step urokinase catalyzes cleavage of Arg65°-Val561 peptide 
bond forming two chains linked through a disulfide bond. In the second 
step the Lys76-Lys77 peptide bond is hydrolyzed by autolytic cleavage. 
With this hydrolysis, a whole 1 to 77 N-terminal peptide is removed. The 
resultant plasmin molecule with Mw=75,000 to 81,000 (Robbins and 
summaria, 1976), has a broad trypsin-like specificity towards proteins. 
In normal cells plasminogen activator synthesis can be modulated by 
physiological concentrations of hormones or other biologically active 
compounds (Reich, 1978; Weinstein, 1978). Transformation to neoplastic 
cells may be correlated with increased plasminogen activator synthesis. 
This circumstantial association has been explored by the researchers who 
are interested in the biology of the malignant cells. Most studies 
indicate increased synthesis of plasminogen activator in malignant cells 
compared to normal controls. Because of plasminogen activator's 
association with neoplasia, important purification techniques from 
culture media will be reviewed. 
Goldfarb and Quigley (1980) isolated plasminogen activator 
(urokinase) from culture supernatents of Rous sarcoma virus transformed 
chick embryo fibroblasts treated with the tumor promoter phorbol-12-
myristate-13-acetate (PMA) by multiple affinity chromatography. 
Plasminogen activator was adsorbed on to p-aminobenzamidine-CH 
• 
Sepharose-B at pH 7.0. Following adsorption the resin was washed with 
buffer containing Triton X-100. The enzyme was eluted with buffer 
containing 0.5 M benzamidine at pH 4.0. All the fractions were dialyzed 
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to remove benzamidine and the fractions containing enzyme were pooled 
and re-adsorbed on benzamidine adsorbent at pH 7.0. The enzyme was 
eluted and fractions were dialyzed to remove benzamidine as previously 
described. Active fractions, partially purified and concentrated by two 
rounds of affinity chromatography were subjected to a molecular sieving 
gel (G-100 Sephadex) at 4°C. Plasminogen activator containing fractions 
from gel-filtration were dialyzed and applied to cation exchange resin 
(sulfopropyl-Sephadex C-25) at 4°C. The enzyme was eluted by stepwise 
increase of ammonium sulfate concentration and each fraction was assayed 
for protein and enzyme concentration. The final yield of enzyme was 43%. 
The enzyme activity profile demonstrated a major plasminogen activator 
activity of 46,000-48,000 daltons and a minor activity of 23,000-26,000 
daltons. 
Dano .tl. .a.J......, ( 1980) and Maroti .tl. .a.J......, ( 1982) also reported 
purification procedure of plasminogen activator from mouse cells 
transformed by an oncogenic viruses using an affinity adsorbent 
containing p-aminobenzamidine as the ligand. In the procedure, serum 
free media was brought to pH 5.5 and passed over p-aminobenzamidine-
aminocaproyl-Sepharose. After washing the column with 0.5 M NaCl, the 
proteins were eluted with buffer containing 0.9 M benzamidine at pH 7.4. 
The benzamidine was removed by dialysis against 10 mM Tris-HCl, and pH 
7.4/1 mM zinc acetate. The proteins were recovered as precipitates by 
centrifugation at 12,000xg for 30 min. The proteins were extracted into 
100 mM glycine-HCl, pH 2.2/1 mM zinc acetate. The clear solution was put 
over a QAE-Sephadex A-50 column to further purify. The fractions 
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containing enzyme activity were subjected to preparative gel 
electrophoresis followed by elution with buffer and then dialysis. These 
types of procedures are laborious and low yielding. 
Since benzamidine-Sepharose affinity is a general purpose affinity 
adsorbent for trypsin-like proteases, more specific systems for 
purification of urokinase were exploited using one of the properties of 
urokinase, which is to bind to the fibrin clot. The gel-like consistency 
of fibrin is not practical for the purpose of purification, but fibrin 
deposited on celite was found suitable for affinity chromatography 
(Husain ~ ~ 1981). The procedure involves adsorption of vascular 
plasminogen activator from plasma onto a fibrinlcelite matrix, and the 
elution of plasminogen activator with a buffer containing 0.2 M 
arginine. The fractions containing active protease were subject to gel-
filtration through a Sephadex G-100 column. This high fibrin affinity 
plasminogen activator had a low specific activity of 500 U/mg protein, 
compared to tissue or urine plasminogen activators (100,000 to 200,000 
U/mg). 
Immunological reactivity is highly specific and the binding 
constants are very high between antigen and antibody. Wallen ~ ~ 
(1983) reported a three step purification procedure combining the 
principles of immunospecificity, affinity for arginine and gel-
filtration,in the purification of melanoma cell tissue type plasminogen 
activator. The first step was the adsorption onto an antibody-resin. The 
second step involved chromatography over arginine-sepharose. The third 
step was a gel-filtration on Sephadex G-150. The enzyme was eluted off 
the antibody column with a strong denaturant, 3M KSCN, guanidinium 
chloride (0.3 M). 
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A slight variation of the same procedure was utilized by Booyse ~ 
il· (1984) in the purification of urokinase type plasminogen activator 
from cultured human endothelial cells. In their procedure, the enzyme 
was isolated first by p-aminobenzamidine agarose affinity chromatography 
followed by gel-filtration on Sephacryl-200. The final step involved 
adsorption on anti-urokinase IgG-Sepharose CL-4B. The elution of the 
enzyme was accomplished with 4 M Guanidine-HCl at pH 6.5 buffer 
containing Triton X-100. The overall yield was 49.6% with specific 
activity 94,000 U/mg protein. 
Proteases are commonly synthesized in inactive proenzyme forms and 
are activated by a modulator or by another protease. Anderson ~ ~ 
(1984) showed that tissue-type plasminogen activator from human melanoma 
cells is synthesized in an inactive proenzyme form with a single chain 
(Mw-66,000). A single step purification procedure using monoclonal 
antibody affinity resin is described. Salerno ~ ~ (1984) reported 
the identification of the single-chain prourokinase precursor with 
monoclonal antibodies from rabbit reticulocyte cell free system. This 
prourokinase appears to be the precursor of both the A and B chains of 
human urinary urokinase. 
Human tissue type plasminogen activator has been obtained by 
expression of its cloned gene in a mammalian cell system. Thus, 
plasminogen activator is currently synthesized by recombinant DNA 
technology for commercial purposes and an easy purification technique is 
highlY desirable.Highly purified plasminogen activator promises 
practical approach for coronary thrombosis in patients with acute 
myocardial infarction (Van De Werf ~ .ala., 1984). 
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Tripeptide substrates for plasminogen activators shows its 
specificity for synthetic peptide sequences. Val-Gly-Arg and Glu-Gly-Arg 
tripeptides are specific toward both tissue-type plasminogen activator 
and urokinase. In addition to these two tripeptides, Gly-Gly-Arg and p-
Glu-Gly-Arg also show a high specificity towards both types of 
plasminogen activators (Cleason and Aurell, 1981). The aldehyde 
derivative of these tripeptides should also be highly specific and 
potent inhibitors of plasminogen activator. These tripeptide aldehydes 
could be used as ligands for preparation of affinity adsorbent for a 
single step purification plasminogen activators. Among all the 
tripeptide aldehydes, Gly-Gly-Argal would be the easiest to synthesize. 
The urokinase purified using this affinity adsorbent will be expected to 
be free from other contaminating proteases and proteins. 
~ Thrombin 
Thrombin is a proteolytic enzyme homologous to trypsin, 
chymotrypsin and elastase with Mw-34,000. The biology and chemistry of 
thrombin has been extensively studied over the last fifty years. Major 
attention has been paid to the kinetics and the inhibition of the 
proteolytic action of thrombin on fibrinogen. Thrombin is the enzyme 
involved in the final step of the coagulation of mammalian blood. In 
this step four Arg-Gly bonds are cleaved releasing four fibrinopeptides. 
While it is a highly specific protease, it has a wide specificity 
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towards small synthetic substrates. It is clear that thrombin exists in 
multiple covalent forms which have different specific activities towards 
fibrinogen and ester substrates. These forms are referred to as -~­
thrombin, ,B-thrombin (fig.11 ). ,B-thrombin is formed from ~thrombin by 
the extensive degradation of the A chain and excision of a small 
fragment containing carbohydrate, from B-chain. This results in a three-
chain structure. 2(-Thrombin arises from further degradation of the B2 
chain. Fig 11 shows structures of bovine oc,p and 'd-thrombin (Lundbald, 
1976). The relative activities of.oC-thrombin and,B-thrombin toward 
fibrinogen is 21.6 to 1.0 indicating a major contribution of theO(-form 
towards clotting activity. However, their relative activity toward the 
small synthetic substrates Bz-ArgNaN is only 5.25 to 1.0 (Workman and 
Lundblad, 1977). 
Even though there are a number of known protein substrates for 
thrombin, the kinetics and chemistry of fibrinogen-fibrin conversion by 
thrombin is the most extensively studied. Fig 12 shows a primary 
structure model of human fibrinogen. In the Figure, the chains have been 
aligned according to homology, the N-termini pointing towards the 
middle. The connecting links represent disulfide bridges, the arrows 
point to the thrombin cleavage sites and the diamonds point to 
carbohydrate side chains. Fibrinopeptides A and B are peptide fragments 
released from amino-terminal portions of fibrinogen upon thrombin 
catalyzed gelation. The physiological role of these peptides in the 
protein is to prevent spontaneous polymerization of the fibrinogens. The 
amino acid sequence and length of fibrinopeptides A and B is species 
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Figure 11. Diagramoatic structures of bovine thrombins. 
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Fig. 12. Structure of Fibrinogen 
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dependent, indicating they can serve as markers for studying phylogenie 
relationships and the evolutionary process of primates on a molecular 
level (Nakamura ~ ~ 1983). Fig 13 shows the amino acid sequences of 
human and bovine fibrinopeptide-A (FPA) and fibrinopeptide-B (FPB). The 
kinetics of the released of the fibrinopeptides show an initial and 
rapid released of FPA, followed after a lag phase by the release of FPB. 
The A and B chains behave independently in their competition for 
thrombin. Phosphorylation of the Ser-3 of the A chain appears to 
increase the rate of its release, due to enhanced binding of thrombin 
(Hanna and Scheraga, 1984). 
Initially thrombin was purified by ion-exchange chromatography. 
Baughman and Waugh (1967) used a combination of DEAE-Cellulose 
chromatography, phosphocellulose chromatography and gel-filtration to 
obtain a preparation with a specific activity of 2100 NIH U/mg for 
bovine thrombin. Affinity chromatography for purification of thrombin 
using p-aminobenzamidine as a ligand has been reported (Schroer, 1972; 
Hixon, 1973). The benzamidine agarose is a potent affinity adsorbent for 
thrombin. From crude thrombin, a 16-fold purification was obtained. The 
preparation also contained small amounts of plasmin and had to be 
further purified on SE-sephadex column to obtained 2000 NIH U/mg -OC-
thrombin with an overall yield of 50% to 60%. Electrophoresis showed a 
major and a minor band on a SDS-gel. In the elution of thrombin from the 
benzarnidine resin, 0.05M p-arnino-benzarnidine in Tris-KCl buffer at pH-
8.0 was utilized (Hixon and Nishikawa, 1 973). 
Heparin acts as an anti-coagulant on binding to thrombin at a site 
Fibrinopeptide-A (FPA) 
Human:- Ala-Asp-Ser-Gly-Glu-Gly-Asp-Phe-Leu-Ala-Glu-Gly-Gly-GLy-Val-Arg. 
Bovine:- Glu-Asp-Gly-Ser-Asp-Pro-Pro-Ser-Gly-Asp-Phe-Leu-Thr-Glu-Gly-Gly-Gly-Val-Arg. 
Fibrinopeptide-B (FPB) 
Human:- p-Glu-Gly-Val-Asn-Asp-Asn-Asn-Glu-Glu-Gly-Phe-Phe-Ser-Ala-Arg. 
Bovine:- pcA-Phe-Pro-Thr-Asp-Tyr-Asp-Glu-Gly-Gln-Asp-Asp-Arg-Pro-Lys-Val-Gly-Leu-Gly-Ala-Arg. 
Figure-13. Amino acid sequence of fibrinopeptides. 
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other than the catalytic site. This property of heparin was exploited 
for preparation of an affinity adsorbent for thrombin (Miller-Anderson, 
1980; Funahashi, 1982). Three different types of heparin-Sepharoses can 
be prepared. First, by the coupling of carboxyl groups of heparin with 
amino-Sepharose. Secondly by the coupling amino groups of heparin with 
carboxyl-Sepharose, and, thirdly, by the reductive amination of heparin 
and amino-Sepharose with sodium cyanoborohydride. Among these three 
types of heparin resins, the third type was found to be the most 
efficient affinity adsorbent for thrombin and anti-thrombin III 
(Funahashi, 1982). 
Miller-Anderson (1980) combined all three techniques, ion-exchange 
chromatography, gel-filtration and affinity chromatography to prepare a 
human thrombin standard. In the procedure, a prothrombin complex was 
activated and purified on a CG-50 ion-exchange column followed by 
chromatography on SP-Sephadex and then chromatography on heparin-
Sepharose. The resulting thrombin had a specific activity of 2400 to 
2850 IU/mg. 
These methods are lengthy and if used alone, are not exclusive for 
thrombin. Heparin has affinity not only for thrombin, but also for 
antithrombin III, lipoprotein lipase, collagenase, DNA polymerase and 
number of other biomolecules. Benzamidine-Sepharoses are specific for 
all trypsin-like proteases and bind thrombin, urokinase, plasmin, 
trypsin, etc. A single step purification affinity adsorbent could be 
prepared using a specific active site inhibitor of thrombin as a ligand. 
As discussed previously Phe-Pro-Argal offers the required 
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characteristics for this purpose. Accordingly, in this dissertation an 
Affi-gel-Phe-Pro-Argal .resin will be prepared and tested for its utility 
as an affinity adsorbent for the purification of thrombin. 
The amino acids in fibrinopeptides from many species differ in the 
p2 and P3 positions. The Phe at position Pg is conserved, suggesting 
the importance of Phe in Pg position for thrombin action. Marsh and 
Scheraga (1982) synthesized the fibrinopeptide sequences Ac-Phe-Leu-Ala-
Glu-Gly-Gly-Val-Arg-Gly-Pro-NHCH3 (F-6) and Ac-Leu-Ala-Glu-Gly-Gly-Gly-
Val-Arg-Gly-Pro-NHCH3(F-7) and the rates of hydrolysis of Arg-Gly bond 
in these peptides by thrombin were measured. The rate for the Phe 
containing peptide F-6 was found to be significantly larger than that 
for F-7. Indeed, F-7 is such a poor substrate that it was not possible 
to obtained Michaelis-Menten parameters. This and previous work 
demonstrate that Phe-Leu at position Pg-Pa is very important for 
thrombin binding to its substrate. The work was extended further to 
investigate the importance of Asp at the P10 position, which indicates 
that Asp(P10) is also important for thrombin fibrinogen interactions 
(Marsh and Scheraga, 1983). On the basis of these observations and high 
affinity of Phe-Pro-Arg for thrombin, a hairpin-like structure in the 
NH2 terminal of the A chain of fibrinogen is proposed. Additional bends 
I I , . present at Pro-Arg (P 2-P 3) and poss1bly between P4 and Pa br1ng the 
Phe(Pg) close to Val-Arg-Gly. In other words Phe can occupy s3 position 
in thrombin. 
This leads to a conclusion that in the design of a small specific 
inhibitor of a protease, the selection of amino acid sequence may not 
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necessarily have to be based upon substrate sequence. There is one 
consolation to this, that is, there are only 20 or so common amino 
acids. However, the permutations of these could become very difficult 
when dealing with an unknown protease. This problem could be solved by 
using the natural substrate of the protease. This plan of attack is 
explained in a later section. 
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~ Peptide synthesis 
This rather narrow area of bio-organic chemistry has received 
considerable attention. It is impossible to review all the methodologies 
to synthesize peptides, therefore only cases pertaining to this research 
will be discussed. The formation of the peptide bond requires activation 
of the carboxyl group of an amino acid. The reactive intermediate of the 
amino acid then reacts withoC-NH2 of another amino acid to form the 
peptide bond. The reversible protection of the amino group and of the 
carboxylic group which were not meant to be part of the amide bond, 
remained problematic for a long time. A major break through toward the 
solution of this problem was the discovery of the carbobenzoxy group. 
This protecting group could be easily removed by catalytic hydrogenation 
at room temperature and ordinary pressure, and generates relatively 
harmless by products, toluene and carbon dioxide. Since the guanidine 
group of arginine is a nucleophile, it should blocked to prevent 
undesirable reactions. There are three amino groups in the guanidine 
which is a single, monoacidic cation. The basicity of the guanidine 
group in arginine is extreme, and it remains protected under the usual 
conditions of peptide synthesis by simple solution protonation. In this 
Dissertation, I have N02 protection of the guanidine group to promote 
the solubility of Arginine peptides in tetrahydrofuran (THF). This No2 
protection can be removed under similar conditions to remove the 
carbobenzoxy group, the only difference is the requirement for acid and 
a longer reaction time. During deprotection of the N02, special care 
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needs to be taken against the reductive saturation of aromatic nucleui 
and other unsaturated bonds (Galpin ~ ~ 1984). Other problems with 
guanidine protection with N02 are reviewed in detail by Bodanszky 
(1984). 
The aldehyde function is reactive towards even weak nucleophiles, 
and has to be protected from participating in undesirable nucleophilic 
reactions. This protection should be easily removable under mild 
conditions to regenerate the aldehydic function. There are number of 
ways to accomplish this goal. Without going into detail, two distinct 
alternatives are either to prepare the acetal or the semicarbazone 
derivative. Both methods are easy, but acetals are acid labile and 
during removal of the N02 protection of the guanidine group, the acidic 
conditions may also remove the acetal aldehyde protection. 
Semicarbazones are relatively stable to acids. Also it is advantageous 
because of the low solubility of the semicarbazone products, which will 
help in crystallization of the aldehyde derivative. 
The carbonyl group can be activated in a number of ways. One of the 
most popular methods is the conversion of protected amino acids to 
reactive esters, Z-NH-CHR-COOR', where R' is an electron-withdrawing 
group. From numerous active esters in the literature, N-hydroxy 
succinamide esters were selected herein (Anderson, 1963, 1964) because 
of the water solubility of the products of the hydrolysis. The N-hydroxy 
succinamide esters are crystalline, stable compounds which have 
excellent reactivity in aminolysis reactions. The synthesis of N-hydroxy 
succinamide esters are not different from the formation of a peptide 
bond. The N-protected amino acid is allowed to react with N-hydroxy 
succinamide in presence of an acyl transfer reagent, for example a 
carbodiimide (Bodanszky, 1957). 
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In the case of utilization of a carbodiimide catalyst, the 
activation of carboxyl group occurs through its addition to N:C double 
bond of the carbodiimide. Fig. 14 shows the most commonly used 
carbodiimides. Dicyclohexyl carbodiimide (DCC) was introduced by Sheehan 
and Hess (1955). The water soluble variant of DCC is N-ethyl-N-(3-
dimethylaminopropyl) carbodiimide (EDC). There are other water soluble 
variants, but EDC seems to give better coupling yields (Bodanszky, 
1984). Fig. 15 shows a carbodiimide mediated peptide bond formation. The 
by product of the coupling reaction is an isourea. In the case of DCC 
the N,N'-dicyclohexyl urea is insoluble in most organic solvents and 
removed by filtration. A water soluble carbodiimide is advantageous in 
certain cases because of the solubility of the urea by product. This is 
particularly useful when the desired product is linked to an insoluble 
support. 
Proteolytic enzymes also can be used as coupling reagents by 
thermodynamically or kinetically controlled enzyme catalyzed aminolysis 
of specific acids or esters. In recent years protease catalyzed peptide 
synthesis has undergone intensive development. Enzymic synthesis 
processes a number of advantages over chemical synthesis. Since it does 
not require an activation of a carboxyl group, functional side groups 
amino acids do not have to be protected. In addition, these reactions 
are stereospecific and undesirable racemization does not occur. Several 
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Dicyclohexylcarbodiimdde 
HCl 
I 
CH~C~-N:C:N-C~-C~-N(CH3)2 
N-ethyl-N'-(3-dimethylaminopropyl)carbodiimide 
(water soluble carbodiimide) 
diisopropylcarbodiimide 
Figure-14. Structures of carbodiimides. 
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carbodiiminde 
isourea 
Figure-15. Carbodiimide coupling reaction. 
papers devoted to successful synthesis of various peptides using 
chymotrypsin, papain, subtilisin, trypsin, carboxypeptidase and other 
proteases have been published (Mitin, 1984). 
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Conditions have to be worked out to shift the equilibrium in such a 
manner that the enzyme remains catalytically active and peptide bond 
synthesis is favoured rather than peptide bond hydrolysis. Three 
different techniques have been applied to achieve this goal, mass action 
(Sealock and Laskowski, 1969), change in pH (Mitin ~ ~ 1984) and 
addition of an organic co-solvent to change the equlibrium in favor of 
the peptide synthesis(Homanberg and Laskowski, 1978; 1979). 
In the first technique, a des-arg modified protein was reacted with 
large quantities of arginine, trypsin and carboxypeptidase-B. This 
procedure succeeded in adding the initially removed Arg residue back to 
the des-Arg protein. In the second technique, Mitin ~ ~ (1984) 
synthesized peptides in the presence of papain at pH 8 to 9 using 
acylamino acid alkyl esters as starting substrates and peptide 
nucleophiles (amides or tert-butylesters of amino acids as well as 
peptides) as amino group donating compounds. In the third technique 
(Sealock and Laskowski, 1969), the pH dependence of Ksyn in water and in 
60% (v/v) triethylene glycol was varied and conditions found that 
thermodynamically favored peptide bond synthesis in the chymotrypsin 
mediated peptide bond formation between Cbz-Try and Glu-NH2• In the 
study of the resynthesis of the peptide bond between bovine pancreatic 
ribonuclease S and S peptide by subtilisin in water, the maximal amount 
of synthesis was only 4.3%. By increasing the glycerol concentration to 
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go% (v/v) glycerol, the glycerol perturbed the equlibrium between 
synthesis and hydrolysis so that at equlibrium, 50% of the RNAase was in 
the natural covalent form. 
~ Rational fQr utilization Q[ fibrinogen-thrombin system fQr ~ 
development Qfa general method !QL protease affinity 
chromatography 
The example of thrombin was selected to demonstrate a general 
method of affinity chromatography herein because the chemistry of 
fibrinogen-thrombin system is known. In addition to this 
fibrinopeptides are commercially available and the potential problems of 
side chain coo- groups modification could be studied. Since the amino 
terminal residue of FPB is p-Glu, it is not available to form a linkage 
between FPB and the resin matrix. This leaves FPA as the possible choice 
for immobilization on the resin. The FPA is immobilized rather than 
fibrinogen for two important reasons. First, the activation of 
immobilized fibrinogen by thrombin will lead to formation of a large 
clot entrapping all the matrix beads. Secondly, since fibrinogen is a 
very large molecule (MW= 340,000), a high ligand concentration can not 
be achieved due to molecular weight differences between the by product 
fibrin and desired product (FPA). However, a very high concentration 
could be achieved on the matrix if FPA is added directly to the resin. 
During the coupling of ArgSc to des-ArgFPA, the side chain coo-
groups of glutamate and aspartate have the potential to be modified by 
the reaction. This problem could be remedied by either the selective 
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reversible modification of these acid groups or by the use of an enzyme 
reagent to form the peptide bond with a specificity to the C-terminal 
carboxylic group. Both approaches are attractive and will be later 
discussed. 
Fibrinopeptide-A will be covalently joined to an affinity resin by 
one of the standard procedures previously discussed. This resin 
containing fibrinopeptide-A will be treated with carboxypeptidase-B to 
remove the terminal arginine residue. Carboxypeptidase-B is commercially 
available in high purity and exhibits preference in the removal of basic 
amino acids like arginine and lysine. The release of free arginine from 
the peptide can be directly followed by the Sakaguchi test (Messineo, 
1966). Following removal of the COOH-terminal arginine, Arg-Sc 
(argininal semicarbazone) (Patel and Schultz 1983) will be added to the 
desarginine peptide. The simplest way to do this is by a chemical means 
utilizing a water soluble carbodiimide to catalyze peptide bond 
formation. 
An apparent difficulty with this scheme is that the addition of the 
Arg-Sc will not only be to the desired COOH-terminal group of the des-
Arg FPA, but also to the Glu and Asp carboxylic acid side chain groups. 
Whether the effect of these added Arginals make any difference in the 
binding of thrombin to the affinity resin remains to be seen. However, 
the nonspecific addition of Arg-Sc could be avoided by revesibly 
modifying COOH side chain groups or using proteases as reagent for 
peptide bond formation as discussed previously. In the reversible 
modification approach, methyl ester protection of these COOH groups is 
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very attractive. This protection could be obtained using triethyl 
oxonium fluoroborate (Merwein reagent) in aqueous solution (Hamada and 
Yonemitsu, 1971; Paterson and Knowles, 1972; Osbahr, 1982). The methyl 
esters could be easily hydrolyzed at pH 12 within a short period of time 
after the C-terminal arginine is converted to argininal. A number of 
different techniques can then be used to substitute the terminal 
arginine by Arg-Sc. 
Chapter III 
MATERIALS AND METHODS 
~ General Materials £nd Sources 
Unless otherwise stated the chemical reagents utilized in this work 
were reagent grade or better. Reagents were generally purchased through 
the Eastman Chemical Company, Scientific Products (S/P), J.T. Baker 
Chemical Company or from the Malincrodt Chemical Works. Special 
instruments utilized in this work are indicated at the appropriate 
places. 
Specific mixtures of developers (CH3oH:CHC13:15:90 and others as 
indicated) were formulated to develope thin layer chromatography (TLC) 
plates were prepared each day and were used only once. Specific spray 
reagents were prepared intermitantly as per requirements to maintain 
optimum sensitivity. Appropriate buffers were freshly prepared and 
stored at 4 °c. Affinity resins were also stored in CH3:H20/50:50 at -
20 °C and equilibrited with appropriate buffer overnight before use. The 
substrate solutions were prepared according to required concentrations 
and stored at -20 °C in 2 ml aliquot. Enzyme solutions also were prepared 
according to their desired concentrations and stored at -20 °C in 
appropriate aliquots. 
Because of its higher sensitivity of silica gel plates Bakerflex 
IB2F (fluorescent type) from J.T. Baker Chemicals towards the Sakaguchi 
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test, IB2F plates were used where the Sakaguchi test was performed. If a 
Sakaguchi test was not required, silica gel plates GF from Analtech 
(cat# 02521) were used. 
Bovine fibrinogen type IV containing approximatly 40% buffer salts 
(sodium citrate/sodium chloride::0.02:0.85) was purchased from Sigma 
chemicals (cat# F-4753) and was used without further purification. 
Human fibrinogen containing approximatly the same buffer salts as 
bovine fibrinogen was purchased from Sigma Chemical (cat# F-3254) and 
used without further purification. Bovine thrombin was purchased from 
Miles Lab. (85 NIH units/mg protein, Lot# 82-03615), bovine trypsin from 
Millipore Corp. (LOt# 3703 TRL 39N993P), and human urokinase from Abbott 
Laboratories (Abbokinase, Lot# 19-022-AF, 150,000-200,000 I.U/mg 
protein). 
The following are the spray reagents for identification of 
different functional groups in peptide derivatives. 
Dinitrophenylhydrazine (DNP) test: To identify aldehydes, aldehyde 
hydrates or semicarbazones on TLC, the developed and dried silica gel 
plates were initially sprayed with a solution of dinitrophenylhydrazine 
(DNP) (Aldrich) in ethanol containing 1% concentrated HCl and dried at 
80 °C in an oven for 10 min. To enhance the sensitivity, the plates were 
subsequently sprayed with a solution of 0.2% potassium ferricyanide 
(Fisher) in 2 N HCl which upon drying destroy the yellow color of 
unreacted DNP and the aldehyde or semicarbazone are amplified by their 
yellow color. 
Sakaguchi test: The chromatogram is sprayed with a mixture of a 16% 
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urea solution followed by 0.2% ethanolico<-naphthol solution. The plate 
is dried at 80 °C for 10 minutes and subsequently sprayed with a 
solution of 3.3 ml bromine in 500 ml 5% NaOH solution. 
Ninhydrin test: 100 mg of ninhydrin was dissolved in 100 ml of 
acetone. After spraying the chromatogram with the ninhydrin solution, a 
pink to purple color appears upon heating at 80 °C for 10 min. 
Iodine chamber: A few crystals of iodine are kept in an air tight 
wide-mouth glass jar and a dried chromatogram is allowed to react with 
the iodine vapor for 10 min. 
Schiff's reagent: 1 gm of basic fuchsin (Sigma Chemicals) is added 
to 200 ml of distilled water at 90 °C and stirred to disolve. The 
solution is cooled to 50 °C, filtered, and 20 ml of 1 N HCl added. The 
solution is further cooled to 25 °C, 1 gm of sodium bisulfite added, and 
the solution kept for 18-20 hours in the dark. To the straw colored 
solution, a few grains of activated charcoal is added to decolorized 
the solution. The reagent is stored at 4 °c in a tightly stoppered brown 
bottle. The solution is discarded when a pink color appears. 
~ Synthesis Q[ Cbz-(NO~)-L-Arginine Semicarbazone 
(Cbz-NO~-Arg-SC 
I have published the synthesis of this compound (Patel and Schultz, 
1982). To a solution of 2.02 gm (5.72 mMoles) of Cbz-N02-Arg in 15 ml of 
anhydrous tetrahydrofuran (THF)(Malincrodt) under nitrogen was added 1.0 
gm of 1,1'-carbonyl diimidazole (Sigma). The solution was stirred at 10 
88 
oc untill all the solids dissolved and then cooled to -75 °C (dry-ice 
acetone bath). To the solution was added 0.84 gm of LiAlH4 in 17 ml of 
THF over 30 minutes and the mixture stirred for 3 hr at -75 °C under N2. 
Unreacted LiAlH4 was decomposed by the addition of 50 ml cold 2N HCl to 
pH-3.0. The reaction was extracted 3 times with CHC1 3, the CHC1 3 extract 
washed with H2o, dried over anhydrous Na2so4, filtered and evaporated to 
dryness under vacuum on a rotary evaporator. The white residue (impured 
Cbz-N02-Argal) was dissolved in 80 ml of 70% ethanol to which 1.20 gm of 
semicarbazide.HCl and 1.84 gm of sodium acetate were added. The solution 
was warmed briefly to 60 °C and the solvent evaporated under vacuum. The 
residue was purified on a silica gel column eluted with 10% CH30H in 
CHC1 3, yielding 1.5 gm (66.4% yield) of Cbz-N02-Arg-Sc, crystallized 
from absolute ethanol, mp. 105-108 °C (uncorrected) (Lit. 107-109 °C), 
TLC over silica gel GF plates gave a single spot of Rf=0.19 in 
90:15::CHCl3:cH30H. 
~ Removal Q[ CBz £nd NO~ protection frQm CBz-NO~-Arg-Sc. 
Cbz-N02-Arg-Sc (50 mg) was dissolved in 20 ml of CH30H. To the 
solution was added 5 mg of palladium black (Aldrich Chemical Co), 5 ml 
of H2o and 0.2 ml glacial acetic acid. The mixture was placed in a Parr 
hydrogenator, reduced for one hour at room temperature and 5 lb/in2 of 
hydrogen gas pressure. The mixture was then subjected to centrifugation 
to remove the catalyst. The catalyst was washed twice with 5 ml portions 
of CH30H to recover adsorbed Arg-Sc from the catalyst. The washings and 
supernatent were combined and evaporated at 30 °C to drynes under vacuum 
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in a rotary evaporator. To the concentrated Arg-Sc was added 10 ml of 
H20 and then the solution was evaporated (to dryness to remove traces of 
acetic acid). The residual Arg-Sc was used in experiments without any 
further purification. 
~ Synthesis Q[ Cbz-NO~-Arginine diacetal (Cbz-NO~-Arg-OCH3ll 
A solution of 2.02 gm (5.72 mMoles) of CBz-N02-Arg in 15 ml of 
anhydrous THF under nitrogen was stirred at 10 °C until all the solids 
dissolved, and then cooled to -75°C (dry-ice acetone bath). To the 
solution was added 0.48 gm of LiAlH4 in 17 ml of THF over 30 minutes and 
the mixture stirred for 3 hrs at the same temperature under N2• 
Unreacted LiAlH4 was decomposed by the addition of 50 ml of cold 2 N HCl 
to pH 3.0. The reaction was extracted three times with CHC13, the CHC1 3 
extract washed with H2o, dried over anhydrous Na2so4, filtered and 
evaporated to dryness under vacuum on a rotary evaporator. The white 
residue was dissolved in 20 ml CH30H and to the solution was added 4 gm 
of sodium bisufite in 20 ml of water. The solution was stirred at room 
temperature for 20 minutes. The pH of the solution was adjusted to 6.8 
to 7.0 with sodium carbonate and let it stirred for an additional 20 
minutes. The solution was washed three times with 50 ml CHC13. The pH 
of the solution was adjusted to 9 to 10 and was evaporated under vacuum 
on a rotary evaporator to 20 ml. The solution was extracted three times 
with CHC13, the CHC13 extract washed with H2o, dried over anhydrous 
Na2so4, filtered, and evaporated to dryness under vacuum on a rotary 
evaporator, yielding 1.21 gm Cbz-N02-Argal (70% yield). The aldehyde was 
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dissolved in 100 ml of absolute methanol and 200pl of concentrated HCl 
added in 50JU1 portions with stirring, and the reaction mixture stirred 
ror 10 minutes. The Cbz and N02 protections were removed by catalytic 
hydrogenation as described before and was used without any further 
purification. 
~ Activation Qf Enzacryl AH 
Enzacryl AH (100 mg) was placed into a test tube and stirred in 10 
ml of 2 N HCl at 0-5°C. To the mixture, 4 ml of 4% ice-cold sodium 
nitrite was added with stirring, the mixture stirred for 15 minutes, and 
the resulting diazo-enzacryl AH washed four times with 5 ml portions of 
borate buffer (pH-9.2). The resin was added to a solution of 28 mg of 
Arg-Sc in 5ml borate bufer/10 ml methanol and stirred over night. The 
next day the resin was collected on a sintered glass funnel and washed 
with 0.01 N borate solution. Excess unreacted active groups were 
neutralized by stirring the resin in 1 M ethanol amine (pH 9) for one 
hour. 
~ Synthesis Q( Affigel-Argal Resin. 
Cbz-N02-Arg-Sc (50 mg) was reduced as described above and the 
resultant Arg-Sc dissolved in 4:1/ CH30H:phosphate buffer (0.025 M sodium 
phosphate, pH 7.5), and the solution cooled to 4 °C. Affigel-10 (7 ml) 
(Bio-Rad Corp.) was collected in the sintered glass funnel and washed 
three times with 7 ml portions each of isopropanol. The washed gel was 
added to a pre-cooled Arg-Sc solution, shaken over night at 4 °C, the 
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resin washed with CH30H:H2o (4:1) to remove excess Arg-Sc, the resin 
added to 10 ml of 1 M ethanol amine at pH 8.0, stirred for two hours, the 
resin collected and washed with H2o. To remove the semicarbazone 
protection, the resin was added to a solution of CH30H:CH3COOH:HCHO 
(5:1:1) and stirred overnight at room temperature. The Affi-Argal resin 
was collected on a funnel, washed with H2o, and equilibrated in the 
protease binding buffer prior to the use. 
~ Synthesis Q( ~ Ethanolamine Resin 
To 10 ml of Affigel-10 was added 10 ml of 1 M of ethanol amine at 
pH-8.0, the mixture mixed for mixed for 3 hrs at room temperature, the 
resin collected on a funnel and washed with cold H2o. The resin was 
stored as described previously. 
~ General Procedure EQr ~ Synthesis Q( R-{X-Y-Arginal) Resins 
The affinity resins of general formula R-(X-Y-Arginal) were 
prepared by dissolving 50 mg of the respective dipeptide -X-Y- (-X-Y-= 
Phe-Ala, Phe-Pro, or Gly-Gly) in a solution of methanol/buffer (0.025M 
sodium phosphate at pH-7.5), cooling to 4 °C, adding 5 ml of washed 
affigel-10 and the mixture shaken over night in an inverting shaker at 
4 °C • The resin was collected on a sintered glass funnel, washed with 
methanol/water, the resin added to 10 ml 1 M ethanol amine (pH-8.0) to 
block any unreacted N-hydroxy succinimide ester groups, the mixture 
shaken for 5 hrs, the resin collected on a funnel and washed with water. 
The R-(X-Y) resin was then added to a 4:1 methanol/water solution 
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containing 50 mg of Arg-Sc and a 5-10 fold molar excess of water soluble 
carbodiimide (EDAC, Pierce Chemical Co), the solution brought to pH 4.5, 
and mixed in an inverting shaker over night at room temperature. The 
resin was collected on a sintered glass funnel and washed with 4:1 
methanol/water, the washed resin added to a solution of 3:1:1 methanol/ 
acetic acid/ formaldehyde (37%), and mixed overnight in an inverting 
shaker to remove the semicarbazone protection and generate the free 
argininal. The resin was collected on a sintered glass funnel, washed 
with water and equilibrated with buffer prior to use. 
~ Chemical Analysis Q( Resins 
1. Chemical analysis for guanidine function 
Chemical analysis for guanidine function in resins and solutions 
was carried out similar to a method described by Messineo (1966) with 
modifications described: The reagents were prepared in the following 
manner: 
Reagent A:- Four hundred mg of KI was dissolved in 100 ml of deionized 
water. 
Reagent B:- To 100 ml of 2 M KOH was added 2 g of potassium sodium 
tartarate, followed by 100 mg of 2,4-dichloro-1-naphthol (Eastman Chern. 
Co.). To the solution, 180 ml of 95% ethanol was added. The solution was 
allowed to stand overnight before use. 
Reagent C:- Twenty ml of commercial NaOCl (approximate concentration 4-
6%) was diluted with 80 ml of deionized water. 
For qualitative and quantitative analysis of guanidine function, 
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the reagents were used in the following manner: To the resin or the 
sample solution in acidic medium (pH 1 to 2) containing 1 to 5 ug of 
arginine, 0.3 ml of reagent A and 1.0 ml of reagent B were added in this 
order. After standing for few minutes at room temperature, 0.2 ml of 
reagent of reagent C was added. After 10 minutes the absorbance was 
measured against a blank at 520 nm. One or two standards were used each 
time to assure accuracy for variations in different batches of reagents. 
2. Aldehyde concentration in the resin. 
Quantitative analysis for the aldehyde concentration in the resin 
was based on an analytical procedure previously described by Ulbrich and 
Schellenberger (1979) (Patel and Schultz (1982)) as follows. To 0.1 ml 
of Argal-resin was added a saturated solution of p-phenyl-azoaniline in 
ethanol and acetic acid (10:1), the mixture incubated for 1 hr, and the 
resin washed with ethanol until the eluent is colorless. The resin is 
added to 1 ml of 8:1:1 methanol:acetic acid:salicyl aldehyde and shaken 
for 30 min, the supernatent collected, and the procedure repeated 2 more 
times with the same solvent. The supernatents are combined, made up to 
5.0 ml, and the absorbance read at 405 nm with respect to a solution 
obtained by treatment of model ethanol amine-resin in the same way. The 
excitation coefficent for the Schiff adduct of p-phenyl-azoaniline and 
salicyl-aldehyde was determined on a sample of this product 
independently synthesized by procedure previously described (Patel and 
Schultz, 1982). 
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~ General procedure 
1. Preparation of fibrinopeptides: 
To the solution of 0.9% NaCl was added 1 g of either human or 
bovine fibrinogen and was stirred to dissolve at pH 8.5. To the 
solution, 20 units of purified thrombin and 0.5 ml of 2.5 M CaC12 was 
added, the fibrin clott removed as it is formed by a glass rod, and the 
stirring continue for six hours. The solution was filtered through 
Whatman #1 filter paper followed by filtration through a PM-10 membrane 
filter (Millipore Corp.) under 20 atm. N2 pressure. The filtrate was 
evaporated at 30 °C under reduced pressure to dryness in a rotary 
evaporator. The residue was extracted with 20 ml mixture of 
methanol/water (50:50) and the supernatant evaporated to dryness. The 
residue was now extracted in to 10 ml CH30H/H2o (75:25) and the 
supernatent evaporated to dryness. The residue was reconstituted in 2.5 
ml 0.9% NaCl and loaded on a G-25 superfine Sephadex column (2.5x10 em). 
The column was eluted with the same NaCl solution at flow rate of 1 
ml/min. The peaks determined at 280 om were collected 
2. Synthesis of Affigel-fibrinopeptide-A resin (Affi-FPA) 
Fibrinopeptide-A was dissolved in 4 ml of CH30H/0.05 M imidazole 
(75:25), adjusted to pH 7.4, and cooled to 4 °C. Affigel-15 (7 ml) (Bio-
Rad Corp.) was collected in sintered glass funnel and washed three times 
with 7 ml portions of isopropanol followed by a 10 ml wash of CH30H/H2o 
(75:25). Washed gel was added to pre-cooled FPA solution, shaken for two 
hours at 4 °C, to the slury was added 5 ml of 1 M ethanolamine (pH 8.0), 
shaken for 4 hrs at room temperature, the resin collected, and washed 
with H20. 
3. Synthesis of Affigel-Fibrinopeptide-A-Argal resin (Affi-FPA-Argal) 
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Direct substitution: Affi-FPA and Arg-Sc were prepared as described 
previously. To the solution of Arg-Sc in 10 ml CH30H/0.1 N NaHco3 (5/5), 
in a screw cap test tube Affigel-FPA was added. To the mixture, 0.2 ml 
of carboxypeptidase-B (Type I -DFP, Sigma Chemicals, cat# C 7261, 2 
units/ml in saline) was added and the solution shaken overnight at 37 
°C. Similar reactions were carried out in variable relative amounts of 
methanol and buffer, or with ethylene glycol or other organic solvents 
in place of methanol. 
Chemical method: Affi-FPA and Arg-Sc were prepared as described 
previously Affi-FPA was suspended in 4 ml of 1 M ethanol amine at pH 8.0 
and 200 mg of water soluble carbodiimide (EDAC) was added, reacted 
overnight at room temperature, the resin collected on sintered glass 
funnel and washed three times with water. The resin then was suspended 
in 4 ml of 0.05 M Tris buffer pH 8.1 and reacted with 0.05 mg trypsin 
(Sigma Chemicals, 2X crystallized), or with 100 units of bovine thrombin 
(Miles Laboratories, cat# 82-036-1, Lot# 45) for one hour at room 
temperature. To remove the terminal arginine, Affi-FPA was suspended in 
0.1 M NaHco3 and 0.2 ml of carboxypeptidase-B (2 U/ml in saline) was 
added and reacted for variable lengths of time (30 min to overnight) at 
room temperature or 37 °C. Affi-desarginine FPA was collected in a 
sintered glass funnel and washed three times with normal saline. The 
resin was then added to a 4:1 methanol/water solution containing 
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arginine semicarbazone and 200 mg EDAC, the solution brought to pH 4.5, 
and mixed in an inverting shaker overnight at room temperature. The 
resin was collected on a sintered glass funnel and washed with 4:1 
methanol/water, the washed resin added to a solution of 3:1:1 
methanol/acetic acid/formaldehyde (37%), and mixed overnight in an 
inverting shaker to remove the semicarbazone group and generate the free 
argininal. The resin was collected on a sintered glass funnel, washed 
with water and eqilibrated with buffer prior to use. 
In addition to the ethanol amine protection for side chain coo-
groups, -OCH3 protection was also attempted. To 1 mg of human 
fibrinopeptide-A in 2 ml of methanol/water (3:1) was added 120 ul of 
trimethyloxyfluoroborate (TMOFB) (CH3)30(BF4) in CH3CN (100 mg/ml) in 
10 ul fractions during 30 minutes. During addition of the reagent, the 
pH was kept between 4.5 to 5.5 with the addition of 0.5 M NaOH. The pH 
was adjusted to 7.0, stirred for 30 minutes at room temperature, and 
cooled down to 4 °C. Affigel-15 (7 ml) was washed with isopropanol as 
described before, and reacted with above solution for 60 minutes at 4 
°C, 3 ml of 1 M ethanolamine added, and mixing was continued for an 
additional one hour at room temperature. The resin was collected on a 
sintered glass funnel and washed with water. The gel was added to 4 ml 
of 0.025 M imidazole containing 0.2M NaCl, 0.025M CaC12, and 0.01% 
carbowax-20M at pH-7.4. To the mixture 10 units of thrombin were added 
and reacted for one hour at room temperature. The gel was collected on a 
sintered glass funnel and washed with saline. The terminal arginine was 
removed with carboxypeptidase-B as described previously Arg-Sc was added 
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back to the Affi-desarginine-FPA using water soluble carbodiimide as 
described previously. Semicarbazone proction was removed and the resin 
equilibrated with buffer prior to use. 
Enzymatic synthesis: In this approach papain was used as the reagent to 
form the argininal resin peptide bond at pH 9.2. Affi-desArg-FPA was 
prepared as described previously. The resin was suspended in 3.5 ml 
potassium phosphate buffer containing 0.2 M dithiothreitol, 60 mg of 
Arg-Sc, and 0.2M EDTA at pH-9.2 and 0.5 ml CH30H was added to it. To the 
mixture, 200 ul of papain (Sigma Chemical, CatD P-3125, 2X crystallized, 
22 mg protein/ml, 22 U/mg protein) was added, the pH adjusted to 9.0, 
and the reaction stirred at room temperature. for 15 minutes. The resin 
was colected on a sintered glass funnel and washed with water. 
Semicarbazone protection was removed, and the resin equlibrated with 
water prior to use. 
3K General procedure fQr ~ binding anQ elution Qf proteinases 
1. Column chromatography: The equilibrated 3 ml of resin in an 
appropriate buffer was placed in a small polypropylene column attached 
to an ultraviolate detector (280 nm) with fraction collector. The 
protease solution (1 ml) was diluted with 1.5 ml of the appropriate 
buffer and placed onto the resin. The resin was washed with 7.5 ml of 
initial buffer. The resin was washed with 10 ml aliquots of the same 
buffer, but with a higher ionic strength due to the presence of an 
increasing concentration of NaCl in the buffer. Each of the 10 ml 
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aliquots were analyzed for absorption at 280 nm, for protein 
concentration, and enzymatic activity with an appropriate substrate. In 
some cases smaller fractions were obtained in order to better analyze 
the pattern of proteases. 
2. Enzyme assays: Chymotrypsin and trypsin were assayed with BzTyrEE 
and TosylArgEE respectively, according to the methods described in 
Worthington enzyme catalog (Worthington enzymes, 1977). 
Bovine thrombin and human urokinase were routinely assayed with 
peptide p-nitroanilide substrates in which the rate of appearance of p-
nitroaniline product was determined at 405 nm with a Perkin Elmer 
spectrophotometer (Model# 320). The composition of the reaction 
solutions were as follows. 
Urokinase: at 37 °C 
0.100 ml 1x1o-3 M p-Glu-Gly-Arg-pNA (Kabi Group Inc, S-2444) 
0.8 ml 0.05 M Tris buffer pH 8.4 
0.2 ml protease test solution 
Thrombin: at 25 °C 
0.05 ml 1x1o-3 M D-Phe-Pip-Arg-pNA (Kabi Group Inc. S-2238) 
0.95 ml 0.05 M Tris buffer pH 8.4 
0.020 ml protease test solution 
In some experiments thrombin activity was also measured with the 
substrate fibrinogen which measures mainly the activity of the ~ 
form of the thrombin (Fenton, 1981). In this assay, a stock fibrinogen 
solution (50 mg fibrinogen in 25 ml 0.05 Tris containing 3 mM EDTA, pH 
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7.4) was filtered and adjusted to 1.0 absorption units at 280 nm. This 
solution (200 )Jl) was placed into a Fibrometer (B.B.L., Bectin Dickinson 
and Co), 50 ul of Tris buffer pH 8.1 added, followed by 50 ul of the 
test thrombin solution in the eluting buffer from the affinity resin, 
which always contained 25 mM CaC12• The time interval for formation of 
fibrin clot was correlated with a standard curve of thrombin units ~ 
cloting time, prepared previously under identical conditions. 
Chapter IV 
RESULTS 
4A Synthesis Q( Cbz-N02-Arg-Sc 
Because of the difficulty of direct reduction of carboxylic acids 
to aldehydes, a number of activated carboxylic acid derivatives such as 
acid halides, t-amides esters and lactones have been utilized as 
substrates for reduction. The problem is to stop the reduction at the 
aldehydic stage because the aldehyde once formed is easily further 
reduced to the alcohol derivative. Alternatively, alcohols can be 
oxidized to aldehydes by number of oxidative procedures. Thompson (1973) 
carried out the oxidation of the alcohols by the dicyclohexyl 
carbodiimide-dimethyl sulfoxide reagent, first introduced by Pfiztner 
and Moffatt. Oxidation with pyridinium dichromate seems to cause 
considerable racemization, but Hamada and Shiori (1982) reported 
oxidation of N-protectedf3-amino alcohols by the use of a combination 
sulfur dioxide-pyridine complex and dimethyl sulfoxide in the presence 
of triethyl amine to give highly optically activeo(-amino aldehydes. 
Anderson and Wolfenden (1982) reported the use of horse liver alcohol 
dehydrogenase which shows a broad specificity for its alcohol substrates 
in oxidation of~-amino alcohols tooC-amino aldehydes. 
Despite of difficulty in the direct reduction of carboxylic acids 
to aldehydes, a few methods have been reported that utilized strong 
reducing agents like lithium methyl amine, bis(N-methyl-piperidynyl) 
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aluminum hydride, thexylborane or grignard reagents catalyzed by 
dichloro-bis(cyclopentadienyl) titanium. These methods lack general 
applicability and chemoselectivity because of severe reaction 
conditions. Fujisawa ~ ~ (1983) introduced a simple and 
chemoselective procedure using N,N-dimethyl chloromethylenimium chloride 
and LiAlH(OBut) 3 in a one pot operation. When strong reducing agents 
like LiAlH4 or LiA1(0But)3 are used, the reduction could be limited to 
the aldehydic stage by decreasing temperature below -50 °C. 
Arg-Sc was synthesized by reducing the carbonyl diimidazole ester 
of Cbz-(N02)-Arg with LiAlH4 at -70 °C. Because of unfavourable 
solubility of Cbz-Arg at -70 °C in THF, the guanidine group was 
protected with the N02 group solely for its the favourable solubility. 
The aldehyde function could be protected either by a forming bisulfite 
adduct or by Schiff's base formation. Since strong amine nucleophile 
forms a stable Schiff's base, semicarbazide, a strong nucleophile, was 
selected as a derivatizing agent. Use of a stronger nucleophile than 
semicarbazide could present a problem for the regeneration of the 
aldehydic function. The optimum conditions for acid catalyzed 
semicarbazone formation is around pH 4.0, where the carbonyl oxygen is 
partially protonated and the concentration of unprotonated primary amine 
' is present in low but appreciable amount. Sodium acetate provides a 
conjugate weak acid to provide desirable conditions for the optimum 
acid-catalyzed formation of semicarbazone. 
The degree of racemization during silica gel chromatography varies 
with the structure of the Cbz~-aminoaldehyde. Longer retention times 
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appear to cause more racemization. The semicarbazone derivatives, in 
which keto-enol tautomerism is suppressed, showed little racemization 
during chromatography (Ito ~ ~ 1975). In the case of Cbz-Argal, 
racemization is limited because of the contribution of its non-carbonyl 
carbinolamine structure. From the above two arguments, it is safe to 
assume that purification of Cbz-N02-Arg-Sc during silicagel 
chromatography will lead to little, if any racemization. 
4B. Removal Qf ~ ~ NQZ group protection 
The Cbz and N02 protecting groups of Cbz-N02-Arg-Sc are removed by 
catalytic hydrogenation over palladium black (Aldrich Chemical Co Cat# 
20583-4). The hydrogenolysis was carefully monitored from 2 hrs to 
overnight for complete removal of Cbz and N02 groups (time utilized 
depended upon the activity of the palladium catalyst). Prolonged 
hydrogenolysis produced a side product which was Sakaguchi positive and 
DNP negative. Galpin ~ ~ (1984) showed by NMR that some reduction of 
the carbon-nitrogen double bond in the semicarbazone derivatives may 
occur during hydrogenolysis. To minimize this reduction of the 
semicarbazone double bond, the hydrogen pressure was reduced from 25 
lb/in2 to 5 lb/in2 when highly active catalyst was used. The reaction 
was monitored by the Sakaguchi test and the reaction was stopped at 
after a plateau at A520 was achieved in the Sakaguchi test. 
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~ Enzacryl AH 
Enzacryl AH (Koch-light Laboratories Ltd.) is a hydrophilic 
copolymer containing acyl hydrazide groups as potentially active side 
chains for ligand binding. Fig.16 shows the structural features and 
outlin the coupling procedure used with the Enzacryl AH resin. In the 
procedure, the polymer is activated by the action of dilute nitrous acid 
which converts the acid hydrazides to reactive acid azide groups. 
Primary amino groups will react with the azides at mild conditions (pH 
8.0 to 9.5 and 0-5 °C) to form an amide bond. Accordingly, Arg-Sc in 
borate buffer was reacted with the azide resin to obtain Enzacryl AH-
Arg-Sc. Since this resin is stable to acids and organic solvents, 
regeneration of aldehydic function on argininal was achieved by 
treatment of resin with CH30H/ HCl (2 N)/HCHO (10:2:2). 
The association of trypsin and chymotrypsin was studied by loading 
a mixture of trypsin and chymotrypsin onto a small column (0.9 em x 5 
em) in 0.05 M phosphate buffer. The resin was then washed with 2 ml 
portions of same buffer. Table 8 shows enzyme activities in each 
fraction. It is evident from the results that the resin failed to bind 
either trypsin or chymotrypsin. It was expected that trypsin would bind 
to the column, while chymotrypsin would not show any affinity towards 
the resin. The retention of some enzyme activity on the column was 
nonspecific, and most of the enzyme activity could be easily washed out 
with the initial buffer. Failure to show any specificity towards trypsin 
by the resin led to the search for a different type of resin. 
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Figure-16. Coupling procedure with Enzacryl AH. 
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Table 8 
Relative enzyme activities in 10 ml fractions of column effluents. 
Resin: Enzacryl AH-Argal 
Enzyme: Mixture of 0.5 mg Trypsin and 0.5 mg Chyrootrypsin. 
Buffer: 0.05 M Phosphate buffer containing 0.1 M NaCl. 
Eluting buffer 
Unbound fraction (Initial) 
First wash 
Second wash 
, M NaCl in buffer wash 
~ Enzyme activity 
Trypsin 
72 
5 
9 
Chyrootrypsin 
65 
9.5 
1.8 
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~ Affigel-Argal ~ 
The procedure utilized for the synthesis of Affigel-Argal resin is 
outline in Fig.17. The coupling reaction was monitored by the Sakaguchi 
test before and after reaction of Arg-Sc with the Affigel. Affigel (2.5 
ml) is capable of coupling 30pmoles of Arg-Sc. The resin was also 
qualitatively tested for presence of guanidine group in the same fashion 
as for the Argal in solution. In a positive guanidine test, the resin 
turns a pink color. 
The semicarbazone protection group of the Arg-Sc ligand was removed 
by treating the resin with CH30H:acetic acid:formaldehyde (7:1:2) 
overnight. In this reaction the semicarbazide is transfered from Arg-Sc 
to formaldehyde in a reaction catalyzed by acetic acid. The formation of 
aldehyde in this reaction is qualitatively followed by reaction with 
2,4-dinitrophenyl hydrazine, which gives a yellow color on the resin. 
Alternatively, quantitative analysis of the aldehyde concentration is 
carried out by reaction of the Argal-resin with excess p-phenyl-
azoaniline, which forms a Schiff base with the aldehyde groups (Fig.18). 
After washing the excess p-phenyl azoaniline from the resin, the 
modified resin is treated with salicyl aldehyde, resulting in the 
transfer of p-phenyl-azoaniline from Argal-resin to salicyl aldehyde. 
This adduct is eluted from the resin and quantitated by its absorbance 
at 405 nm. A comparison of the absorption obtained from the p-phenyl 
azoaniline salicyl aldehyde adduct from the Argal resin compared to that 
obtained with an ethanol amine resin blank showed a minimum of 0.1 
pmoles/ml of aldehyde in the Argal-resin. 
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dllmldazole 
Cbz-~-N02)-Arg -----~ 
LIAIH~ 
aemlcarbazlde•HCI 
dlacetate•H-Argai-SC 
Affl Gel 
formaldehyde 
Afflgei-Argai-SC Afflgei-Argal 
HOAc MeOH 
Figure-17. Synthetic scheme utilized in the synthesis 
of Argininal liganded affinity resin. 
RESIN-,hg-CHO + H2NON=N-o 
p-phenylazoani lin • 
salicylaldehyde 
Figure-18. Scheme utilized to analyze Argininal-Resin 
for aldehyde concentration. 
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~ Association Q( trypsin 2nd chymotrypsin tQ Affi-Argal resin 
In a typical experiment, to 3 ml of Affi-Argal resin in 0.025 M 
sodium phosphate (pH 6.0) in a small column (0.9 x 5 em) was added a 
mixture of 0.5 mg chymotrypsin and 0.5 mg of trypsin. When the resin was 
washed with pH 6.0 buffer, in the first 10 ml eluted 100% of the 
chymotrypsin activity placed on the column. The trypsin activity 
remained bound to the resin even after exhaustive washing. The elution 
of trypsin activity was not possible even with 2 N NaCl or at pH values 
between 2.0 and 6.0 (Table 9). However, essentially all the trypsin 
activity was eluted from Affi-Argal resin after incubation of the resin 
with 0.1 N semicarbazide and 0.1 N sodium acetate (pH 3.8) for 15 to 30 
min, and then eluting the trypsin in 10 ml of same reagent. 
Control experiments were carried out utilizing Affi-Arg-Sc and 
Affi-ethanol amine resins. To the Affi-ethanol amine resin no affinity 
of either chymotrypsin or trypsin was observed in pH-6.0 (0.025M sodium 
phosphate) buffer. The trypsin associated with the Affi-Arg-Sc resin at 
pH 6.0 (0.025M sodium phosphate) buffer, but was elute in 1N NaCl 
phosphate buffer at pH-6.0. 
~ Affigel-X-Y-Argal ~ 
1. Synthesis: The procedure utilized for the synthesis of dipeptidyl 
Argal-liganded resin is outlined in Fig.19. The resin matrix containing 
a ten atom diaminoethyl spacer arms activated as N-hydroxy-succinimide 
esters was first covalently linked to dipeptides -X-Y- (where -X-Y-=Phe-
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Table 9 
Relative enzyme activities in 10 ml fractions of column effluents. 
Resin: Affi-Gel-Argal 
Enzyme: Mixture of 0. 5 mg Trypsin and 0. 5 mg Chymotrypsin 
Buffer: 0.025 H sodium phosphate pH 6.0 
Eluting buffer 
Initial buffer (unbound) 
0.2 M NaCl in buffer wash 
2 H NaCl in buffer wash 
10 ml Saline 
(between pH-2.0 and 6.0) 
0.1 N Semicarbazide in 
0.1 N NaOAc pH-3.8 
~ Enzyme activity 
Trypsin Chymotrypsin 
0 90 
0 5 
0 0 
0 0 
100 0 
dllmldazole 
eemlcarbazlde HCI 
NaOAc 
H,IPd 
Argai-SC dlacetate t----- Cbz-(w-N02)-Argai-SC 
l 
EDAC 
dipeptide 
Afflgel-dlpeptlde ~-----
pH 7.5 
Afflgel 
Afflgel-dlpeptldyi-Argai-SC -----~ Afflgel-dlpeptldyi-Argal 
HOAc 
Figure-19. Synthetic scheme utilized in the synthesis 
of dipeptidyl-Argininal liganded affinity resin. 
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Pro, Phe-Ala or Gly-Gly), and then the carboxy terminal of -X-Y- joined 
to Arg-Sc in the presence of a water soluble carbodiimide. It was found 
easier to synthesize the tripeptide aldehyde ligand on the resin in a 
two-step, solid phase procedure than to synthesize in solution the 
complete tripeptide aldehyde and then attach it to the resin. The 
tripeptide synthesis on the resin is N-terminal to C-terminal, which is 
opposite from the commonly utilized Merrifield solid phase peptide 
synthesis. A disadvantage of our N-terminal to C-terminal synthetic 
procedure is that the amino acid Y in the Affi-X-Y resin may be expected 
to racemize during its joining to Arg-Sc. However, the affinity of the 
liganded resins to their selective proteinase was observed to be 
sufficient, and the racemization of the amino acid residue in Y, may 
therefore, not be a serious disadvantage. Furthermore, in the examples 
studied in this work, the Y residue was frequently Gly or Pro, which 
either does not racemize or racemizes with difficulty. 
The semicarbazone protecting groups in the Affi-X-Y-Arg-Sc resins 
were removed by incubating the semicarbazone derivatized resins in 3:1:1 
methanol/acetic acid/formaldehyde (37%) overnight. Our procedure 
successfully substitutes a weak acid for the commonly utilized 0.5-2.0 M 
HCl as the acid catalyst in previous reported procedures (Nishikata et 
al, 1981; Ishii and Kasai, 1981). All resins gave a positive test when 
tested by the Sakaguchi test, as described previously, and gave a 
minimal aldehyde content of between 0.07 and 0.1 umole/ml of resin. This 
analytical procedure for quantitation of aldehyde function. may 
significantly under-estimate the aldehyde content as the yield of the 
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aldehyde chromophore adduct in the analysis is probably less than 100% 
(Patel and Schultz, 1982). 
2. General procedure for the binding and elution of proteases: The 
conditions for binding and elution from Affi-X-Y-Argal resins (-X-Y-= 
Phe-Ala, Phe-Pro, Gly-Gly) of the serine proteinases trypsin, thrombin 
and urokinase was shown in this work. These enzymes have an identical 
primary site specificity toward arginine, but differing secondary site 
specificities towards residues in substrates N-terminal to the amino 
acid containing the scissile peptide bond in their substrates. 
The higher ionic strength buffers decreases the the strength of 
non-covalent ionic interaction and may be expected to elute proteinases 
only bound electrostatically to the resin. For example, proteinases can 
often be remove from affinity resins containing lysine, benzamidine or 
protease inhibitor ligands in buffers of high ionic strength. However, 
in all cases in which the peptidyl argininal showed a high specificity 
to a particular protease (i.e., Gly-Gly-Argal for urokinase and Phe-Pro-
Argal for thrombin), the protease could not be removed with high ionic 
strength buffers. Tables 10, 11 and 12 shows protease activities in 
eluted fraction for the resins Affi-Phe-Ala-Argal, Affi-Phe-Pro-Argal 
and Affi-Gly-Gly-Argal, respectively. 
In the case where concentration of salt failed to elute the 
protease (urokinase from Affi-Gly-Gly-Argal and thrombin from Affi-Phe-
Pro-Argal), the tightly bound protease could be removed in 0.1 M 
semicarbazide containing 0.1 M NaOAc, 0.025 M CaC12 and 0.01 % Carbowax 
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20M. Carbowax 20M was included in the buffer to minimize non-specific 
adsorption of protease molecules to glass and other surfaces. 
Semicarbazide reacts with the argininal aldehyde ligands, forming 
semicarbazone derivatives of the aldehyde groups, and thus acts to 
decrease the affinity of the protease to the resin by decreasing the 
concentration of free aldehyde in the resin. 
3. The example of thrombin: The thrombin utilized in this study is a 
crude commercial preparation from fresh bovine plasma, in which the 
proenzyme has been partially purified by ion-exchange precipitated with 
other contaminants, and then activated by bovine brain thromboplastin 
and calcium. As such it represents a crude preparation of 85 NIH 
units/mg protein specific activity, that serves as a starting 
preparation for further purification. Purified bovine thrombin has a 
reported specific activity of about 2100 NIH units/mg protein (Lundblad 
~ ~, 1976). 
The sequence Phe-Ala-Argal may be expected to have a selective 
affinity to thrombin, based on the observed selective reactivity of the 
chloromethyl ketone derivatives of this sequence towards thrombin 
(Kettner and Shaw, 1979). Therefore, Affi-Gel-Phe-Ala-Argal resin was 
prepared for the study of thrombin binding. Following the application of 
between 20 to 200 units of impure thrombin in sodium phosphate buffer 
(pH 6.0) onto a 3 ml of Affi-Phe-Ala-Argal resin, approximately 72% of 
the enzyme activity bound to the resin. The bound thrombin activity was 
eluted in succeeding 10 ml washes of 0.2 and 1.0M NaCl in phosphate 
buffer (pH 6.0) and in a 10 ml semicarbazide containing buffer (Table 
Table 10 
Relative enzyme activities in 10 m1 fractions of column effluents. 
Resin: Affi-Gel-Phe-Ala-Argal 
Enzyme: Trypsin and Thrombin (separate experiments) 
Buffer: 0.025 M sodium phosphate pH 6.0 
Eluting buffer 
Initial buffer (unbound) 
0.2 M NaCl in buffer wash 
1 M NaCI in buffer wash 
0.1 M Semicarbazide in 
0.1 M NaOAc pH 5.0 
J Enzyme activity 
Trypsin Thrombin 
0 
87 37+13 
0 21+6 
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10). However, almost all the 280 nm absorbing protein (over 99%) was 
eluted in the initial 10 ml buffer, thus giving a dramatic purification 
of the thrombin in these later fractions. The thrombin eluted in the 
later fractions had a specific activity of equal to was at least 2100 
NIH units/mg protein, which is the specific activity reported for 
purified bovine thrombin. 
While thrombin was purified to a high specific activity on the 
Affi-Phe-Ala-Argal resin, the ability to elute a significant amount of 
thrombin activity in the 0.2 M and 1.0 M NaCl buffers indicates that 
thrombin binding is, to a large extent, electrostatic. However, when the 
ligand sequence was changed to Phe-Pro-Argal only 9+2 % of the thrombin 
could be eluted with 0.2 M NaCl. The remaining activity apparently bound 
strongly, and was only eluted in a semicarbazide containing buffer after 
incubation of the resin with semicarbazide for 30-60 minutes to 
dissociate the tightly bound thrombin (Table 11). The higher affinity of 
thrombin towards Affi-Phe-Pro-Argal is in agreement with the observed 
better affinity of thrombin for this sequence in substrate specificity 
and peptide inhibitor studies (Cleason and Aurell, 1981). In contrast to 
the high affinity shown by the thrombin to the Phe-Pro-Argal resin, 
thrombin had no affinity towards the Affi-Gly-Gly-Argal resin (Table 12). 
4. The example of urokinase: The sequence Gly-Gly-ArgOH has a selective 
affinity towards urokinase and plasminogen activators, as this sequence 
has been utilized for the selective assay of these enzymes (Bigbee ~ 
.al..., 1978). On the application of 500-1000 (I.U.) of urokinase through 3 
ml of a Affi-Gly-Gly-Argal resin, the urokinase activity bound tightly 
Table 11 
Relative enzyme activities in 10 m1 fractions of column effluents. 
Resin: Affi-Gel-Phe-Pr~Argal 
Enzyme: Trypsin, Urokinase and Thrombin (separate experiments} 
Buffer: 0.025 M Imidazole containing 0.025 M CaC12, 0.01% Carbowax 20M pH 7.0 
J Enzyme activities 
Eluting buffer 
Trypsin Urokinase Thrombin 
Initial buffer (unbound) 0 100 0 
0.2 M NaCl in buffer wash 3 0 9+2 
1.0 M NaCl in buffer wash 0 0 0 
0.1 M Semicarbazide containing 
0.1 M NaOAc, 0.025 M CaC16, 10 0 86+3 .0.01 J Carbowax 20M pH 5. 
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Table 12 
Relative enzyme activities in 10 ml fractions of column effluents. 
Resin: Affi-Gel--Gly-Gly-Argal. 
Enzyme: Trypsin, Urokinase and Thrombin (separate experiments) 
Buffer: 0.025 M Imidazole containing 0.025 M CaC12, 0.01 J Carbowax 20M pH 7.0 
J Enzyme activity 
Eluting buffer 
Trypsin Urokinase Thrombin 
Initial buffer (unbound) 0 0 88+6 
0.2 M NaCl in buffer wash 3 22+6 
1.0 M NaCl in buffer wash 10 13 3 
0.1 M Semicarbazide containing 
0.1 M NaOAc, 0.025 M CaC16, 102 71-82 0 0.01 J Carbowax 20M pH 5. 
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in the presence of 1.0 M NaCl, and less than 10% of applied activity was 
eluted in semicarbazide buffer under standard conditions. Even washing 
with 0.1 N HCl and 1.0 M NaCl removed only 30-35% of the bound activity. 
However, the addition of both calcium and carbowax 20M (0.01%) to the 
eluting semicarbazide and preincubating the resin with the buffer for 
30-60 min prior to elution increased the yield of eluted urokinase. In 
this way 86+3% of urokinase was eluted with sodium acetate buffer in 
0.025 M CaC12, 0.1 M semicarbazide and 0.01 % carbowax at pH 6.0 
(Table 12). 
5. Separation of urokinase from thrombin on Affi-X-Y-Argal resins. 
Where as urokinase bound strongly to Affi-Gly-Gly-Argal resins, it 
was not retarded by the Affi-Phe-Pro-Argal resins, which bound thrombin 
strongly. In turn, thrombin had a poor affinity to Affi-Gly-Gly-Argal, 
which bound tightly to Affi-Phe-Pro-Argal. Accordingly, the proteinases 
could be separated from one another on either of these resins, as shown 
in Figures 20 and 21. In Fig.20, the elution of a mixture of 83 units of 
thrombin and 500 units of urokinase over Affi-Phe-Pro-Argal is shown. 
The two proteases were dissolved in 4 ml of the imidazole buffer (pH 
7.0), as described previously, and incubated with the resin with gentle 
stirring for 15 minutes. The resin was washed with the original buffer 
followed by 10 ml same buffer containing 1.0 M NaCl. All the urokinase 
activity and a small amount of the thrombin activity was eluted in these 
initial fractions. The buffer was then changed to a semicarbazide buffer 
(0.1 M semicarbazide, 0.1 M NaOAc, 0.025 M CaC12 and 0.01 % carbowax 
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Figure-20. Separation ofc(-thrombin and urokinase on an 
R-(Phe-Pro-Argal) resin. 
, protein absorption (280nm) (left axis) 
•-·-•, urokinase activity (right axis) 
•---•, -thrombin activity (right axis) 
First arrow shows position of the addition of the 
1.0M NaCl to the buffer. Second arrow shows 
position of the change to buffer containing 0.1M 
semicarbazide, 0.1M sodium acetate, 0.025M CaC12 
and 0.01% Carbowax (pH-6.0). 
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Figure-21. Separation ofoC-thrombin and urokinase on an 
R-(Gly-Gly-Argal) resin. 
-----, protein absorption (280 nm) (left axis) 
6- ·-A, urokinase activity (right axis) 
•---•, -thrombin activity (right axis) 
First arrow shows position of the addition of 1.0M 
NaCl to the buffer. Second arrow shows pos ition 
of change to 0.1M Ssmicarbazide, 0.1M sodium 
acetate, 0.025M CaC12 and 0.01% Carbowax (pH-6.0). 
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20M, pH 6.0), which eluted the tightly bound thrombin activity separated 
from the urokinase activity. In Fig.21 is shown the same experiment, but 
over the Affi-Gly-Gly-Argal resin. On this later resin, the thrombin 
activity is eluted initially, followed by the elution of the purified 
urokinase activity in the semicarbazide buffer. 
~ Reproducibility Q( affinity chromatography results and regeneration 
Qf ~ resins 
The results reported in Tables 9,10,11 and 12 are for multiple runs 
on a single resin preparation of any one kind of resin, that was 
continually regenerated after treatment with semicarbazide eluting 
buffers by overnight incubation in methanol/acetic acid I formaldehyde 
at room temperature. Some of the resins have been regenerated in this 
way for more than 40 experiments, without any apparent loss of their 
protease binding ability. In fact, over time the binding to a particular 
resin by a protease appears to get better, rather than poorer, perhaps 
due to a close packing of the resin with use. 
Results between different resins preparations of the same sequence 
showed a greater variability (10-15%) in each of the initially eluted 
percentages over the standard deviation for repeated experiments over a 
single preparation of a resin. Accordingly, the procedure for 
derivatization is not systemized to yield a consistent titer of ligand 
between different preparation of the same sequence. This is perhaps due 
to variation of potency of the catalyst used in hydrogenolysis. In later 
stages of this work, this factor was minimized by the careful monitoring 
of the hydrogenolysis reaction with the Sakaguchi test, as described 
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previously. However, whereas differences exist between different 
preparations of the same Affi-X-Y-Argal sequence resin, they all show 
analogous behavior. Thus, all preparations of Affi-Gly-Gly-Argal showed 
a high affinity toward urokinase; and all Affi-Phe-Pro-Argal resins 
showed a relatively high affinity toward thrombin and no affinity toward 
urokinase. 
~ Example Q( a General Procedure !QL Purification Q( Proteases ~ 
Qll Modification Qf Their Natural Hydrolysis Product 
1. Preparation of fibrinopeptides: Since fibrinopeptides-A constitutes 
less than 1% of the fibrinogen molecule, large amount of fibrinogen was 
utilized to get appreciable amount of fibrinopeptide-A. Fibrinogen (1 
gm) (Sigma Chemical Co.) was used without further purification. Protein 
impurities in commercial preparation with larger than 5000 MW would be 
removed during membrane filtration and smaller contaminants will be 
removed during gel-filtration. The enzyme thrombin releases both 
fibrinopeptide A and B from fibrinogen while the enzyme reptilase 
exclusively releases the fibrinopeptide-A. The presence of 
fibrinopeptide-B will not contribute to the coupling on the resin as its 
NH2-terminal group is blocked and there are no lysines in its sequence 
therefore there is no functional amino group in FP-B to join to resin 
matrix. The stoichiometry of thrombin induced release of fibrinopeptides 
from fibrinogen theoretically release 5.4 mg (3.52 micro moles) 
fibrinopeptids-A from 1 gm of fibrinogen. The Sakaguchi test showed the 
presence of 5.1 to 5.7 mg of fibrinopeptide A and B combined in 
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cH30H:H2o (75:25) extracts, which is about 50% of the theoretical yield. 
The fibrinopeptide fraction from the gel-filtration indicated the 
presence of 3.9 mg (36%) of fibrinogen. Under these circumstances of low 
yields and a long procedure, it was decided to purchase fibrinopeptide-A 
from Sigma Chemicals for further experiments. 
2. Synthesis of Affi-FPA: Because fibrinopeptide-A is a highly acidic 
protein (pi about 3), Affigel-15 which contain a cationic charge in the 
spacer arm, has a significantly higher coupling efficiency than Affigel-
10 as shown in the experiment described below. Out of 2 mgs (1.3 uM) of 
fibrinopeptide-A (from Sigma Chemicals), 1.63 mg was coupled to 5 ml of 
Affigel-10 in CH30H/ imidazole (0.05 M at pH 7.5) I 2.5 M CaC12 
(7 .5/2.5/0.3) overnight at room temperature. In absence of ca+2, the 
coupling of FPA with Affigel-10 was negligible under identical 
conditions. When Affigel-15 was used, almost all fibrinopeptide-A was 
coupled at 4°C in one hour. Since Affigel-15 has 15 umoles /ml coupling 
capacity, unreacted active groups were coupled with ethanolamine by 
adding 3 ml 1 M ethanol amine after the fibrinopeptide-A coupling was 
completed, and letting it react at room temperature for four hours. 
After the reactions were completed, the resin gave a strong positive 
Sakaguchi test, indicating the presence of the arginine containing FPA 
on the resin. 
~ Substitution Q[ terminal Arginine Qy ALgal 
1. Direct substitution: The synthesis of Affi-FPA-Argal was carried out 
in three different ways. In the first approach Arg-Sc was directly 
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substituted for arginine using carboxypeptidase-B as a transacylation 
reagent and Arg-Sc as a nucleophile. In the second approach, arginine 
was removed by carboxypeptidase-B and Arg-Sc was attached to 
desarginine-FPA using a chemical method such as an active ester 
procedure or a carbodiimide coupling procedure, with or without blocking 
the side chain coo- groups of glutamates and aspartates. In the third 
approach, the Affi-desArg-FPA was prepared followed by addition of Arg-
Sc at the coo- terminal using an enzyme as tool to from a peptide bond. 
The procedures utilized for the preparation of Affi-FPA-Argal using 
carboxypeptidase-B are outline in Fig.22. It is difficult to monitor the 
substitution reaction because of presence of large excess of Arg-Sc. 
Since there is even exchange of guanidine group, the qualitative test 
for guanidine groups on resin should remain the same. This leaves 
aldehydic functional group as the only means to follow the substitution 
reaction. Affigel is an agarose and gives some background towards tests 
of aldehyde function, and since the concentration of exchanged Arg-Sc is 
very low, an accurate estimation is extremely difficult. Despite this 
difficulty, the qualitative test of resin with DNP indicated the 
presence of a small amount of Arg-Sc. 
Carboxypeptidase-B (CPB) catalyzes hydrolysis of the basic amino 
acids lysine, arginine and ornithine from the C-terminal position in 
polypeptides. Because of its high specificity for basic amino acids and 
relatively very low activity towards other amino acids, it may be 
possible to carry out trans-peptidation using CPB to exchange arginine 
selectively. Since the free coo- end group is required for CPB action, 
Affi-Gel + Fibrinopeptides 
1 CHjDH/0.05 M ]midazole pH 7.4 (75:25) 
Affi-Gel--FPA 
Carboxypeptidase-B 
Arg-Sc 
organic co-solvent 
Arginine 
Affi-Gel--Fibrinopeptide-A-Arg-Sc 
1cH30HJCH3COOHJHCHO (7:1:2) 
Affi-Gel--FPA-Argal 
Figure-22. Synthetic scheme utilized in the synthesis 
of a FPA-Argal liganded affinity resin using 
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carboxypeptidase-B and the Arg-Sc as a nucleophile. 
(Direct substitution) 
127 
the substituted FPA-Arg-Sc will not be a substrate for CPB and the FPA-
Arg-Sc product, once formed, should be stable in the presence of CPB. 
Sealock and Laskowski, 1969) utilized the same strategy to substitute 
lysine for terminal Arg-64 in soybean trypsin inhibitor by CPB using a 
large amount of trypsin as the product trapping reagent. Along with 
trans peptidation, hydrolysis also occurs during the reaction because of 
the competition of solvent water as a nucleophile. This competition 
could be minimized by a large excess of Arg-Sc and the use of organic 
solvent which inverses the equilibrium towards peptide bond formation. 
The concentration of Arg-Sc is controlled by limited however, by the 
solubility of the semicarbazone derivative, leaving organic solvent as 
the major factor to promote peptide bond formation. Table 13 shows four 
different combinations of organic solvents utilized for preparation of 
Affi-FPA-Argal and the results observed for the binding of thrombin to 
the product resin. The activities of unbound fractions (from 33 to 51 %) 
indicate a lack of strong affinity of the column towards thrombin. 
Mixed solvents using 1,4-butanediol or methanol produced better results 
compared to ethylene glycol or ethylene glycol monomethyl ether. 
Thrombin was retarded to a certain extent in all columns prepared by 
this approach, but the binding characteristics of the columns were far 
below expected levels. 
2. Chemical Modifications: The procedures utilized for the 
preparation of Affi-FPA-Argal using chemical modification are outlined 
in Fig.23. The side chain coo- groups were blocked with ethanolamine 
using a water soluble carbodiimide as a coupling agent, to prevent the 
Table 13 
Relative enzyme activities in 10 ml fractions of column effluents. 
Resin: Affi-Gel--FPA-Ar1a1 (prepared by direct substitution using Carboxypeptidase-B) 
Enzyme: Thront>i n 
Buffer: 0.025 M Cacodylate containing 0.025 M CaC12, 0.01~ Carbowax 20M pH 6.0 
Eluting buffer 
Initial buffer (unbound) 
0.2 M NaCl in buffer wash 
1.0 M NaCl in buffer wash 
0.1 M Semicarbazide containing 
0.1 M NaOAc, 0.025 M CaC12 , 0.01 ~ Carbowax 20M, pH 6.0 
------------
S Enzyme activities 
cn3oH! E tylene 0. 1 N Nanco3 glycol (1:1) 100S 
overnight overnight 
51 73 
51 10 
0 0 
0 
Ethylene 
glycol 
100S 
6 hours 
77 
10 
1 , ll-butanediol 
0.1 M NaHco3 (2:1) 
overnight 
33 
25 
0 
Affi-Gel + Fibrinopeptides 
Jl Imidazole buffer pH 7.~ 
Affi-Gel-FPA 
l Ethanolamine Water soluble carbodiimdde 
Affi-Gel-FPA (ethanolamine) 
Thrombin or Trypsin l 
Tris-pH-8.1 J~ Tenminal ethanolamine 
Affi-Gel-FPA (ethanolamine) 
l Carboxypeptidase-B in 0. 1M NaHC03 
Affi-Gel-des Arg-FPA (ethanolamine) 
l Water soluble carbodiimide + Arg-Sc 
Affi-Gel-FPA-Arg-Sc (ethanol amine) 
l CH30IVCH3COOHIHCHO (7: 1 :2:) 
Affi-Gel-FPA-Argal (ethanol amine) 
(EDAC) 
(EDAC) 
Figure-23. Synthetic scheme utilized in the synthesis 
of a FPA-Argal liganded affinity resin. 
(Chemical method) 
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coupling of Arg-Sc with side chain coo- groups. This procedure produces 
an amide bond formed between the coo- and the NH2 of ethanolamine. The 
COOH-terminal ethanolamine was removed by treating the resin with 
trypsin which specifically hydrolyzes only the C-terminal Arginine-NH-
CH2-cH2oH bond generating a free coo- terminal. This coo- group is 
crucial for CPB action in the removal of the COOH-terminal arginine from 
fibrinopeptide-A and forming desArg-FPA. After a number of trials for 
various lengths of time and different temperatures, it was concluded 
that 40 minutes at room temperature is sufficient to remove most of 
terminal arginine. The maximum amount of arginine released from the 
Affi-FPA was 0.428 umoles (0.66 mg out of 1 mg total on the resin) in 
the first 30 minutes of reaction. This quantitation of released arginine 
is lower than its actual value because of interference from buffer 
components during the Sakaguchi test for arginine. A qualitative test 
for arginine on the resin after CPB treatment showed a very low amount 
of residual arginine on the column. After 30 min of of reaction, the 
residual arginine could not be remove even after 24 hr reaction at 37°C. 
However the exposure of resin to CPB of more than 40 minutes at room 
temperature could remove other terminal amino acids, producing 
heterogeneous ligands on the resin. 
The binding studies of thrombin with the resin were carried out in 
a similar fashion as with the Affi-Phe-Pro-Argal resin. Table 14 shows 
thrombin activities in various fractions of eluents during different 
stages of preparation of the Affi-FPA-Argal resin. It could be seen that 
while the virgin fibrinopeptide-A has some affinity towards thrombin, the 
Table 14 
Relative enzyme activities in 10 ml fractions of col\Bl effluents. 
Resin: Affi-Gel-FPA at various stages. 
Buffer: 0.025 M Imidazole, 0.025 M CaC12, 0.01S Carbowax pH 7.0 
Enzyme: Thrombin 
S Enzyme activity 
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Eluting buffer Affi-FPA Affi-FPA Affi-FPA-Argal 
Ethanol Ethanol amine 
amine 
Initial buffer (unbound) 
0.2 M NaCl in buffer wash 
1.0 M NaCl in buffer wash 
0.1 M Semicarbazide containing 
0.1 M NaOAc, 0.025 M CaC12, 0.01 S Carbowax 20M, pH 5.5 
(overnight incubation) 
50 ott Benzamidine in buffer 
3 M KSCN 
68 
14 
0 
6 11 
0 0 
2 
0 
0 
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ethanolamine treated fibrinopeptide-A does not have any affinity towards 
thrombin and the ethanolamine treated fibrinopeptide-A-Argal prepared by 
chemical method has high affinity towards thrombin. All efforts to elute 
thrombin from the column failed including 3 M KSCN. It should be noted 
here that this particular resin was reacted overnight with CPB to remove 
terminal arginine,and only 30 minutes is required to remove all the 
releasable terminal arginine. However, when only 40 minutes are allowed 
for removal of terminal arginine to assure maximum homogeniety of the 
peptide ligand, and coo- side chain groups are not blocked with 
ethanolamine, lower affinity of the column to thrombin was observed 
(Table 15). 
An alternative to ethanol amine as a protecting group for coo- side 
chains is the use of esters. These esters could be easily hydrolyzed 
under basic conditions. Methyl esters are an attractive alternate to 
ethanolamine groups which could be hydrolyzed easily above pH 10.5. 
Proteins may be sensitive to the acidic conditions of the standard 
esterification procedure which utilizes dry HCl in absolute methanol. In 
addition to denaturation, there is always a danger of 0-alkylation and 
N-alkylation reactions. It would be prefered to carry out the 
methylation in an aqueous medium. However, the main difficulty in such a 
procedure, is the competition of water with the protein for the reagent. 
Trimethyloxonium tetra fluoro borate (TMOFB) was introduced by Mee~wein 
to selectively esterify carboxylic acids in aqueous solutions. This 
reagent has been used to specifically modify the free carboxyl groups in 
proteins at pH 4 to 5 (Osbahr, 1982; Peterson and Knowles, 1972; Hamada 
Table 15 
Relative enzyme activities in 10 ml fractions of column effluents. 
Resin: Affi-Gel-FPA-Argal (prepared by chemical method) 
Enzyme: Thrombin 
Buffer: 0.025 M Imidazole containing 0.025 M CaC12, 0.01 S Carbowax 20M. pH 7.0 
S Enzyme activity 
Eluting buffer 
Affi-FPA-Argal 
Initial buffer (unbound) 0 
0.2 M NaCl in buffer wash 70 
1.0 M NaCl in buffer wash 10 
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Table 16 
Relative enzyme activities in 10 m1 fractions of column effluents. 
Resin: Affi-Gel-FPA-Argal (prepared with -OCH3 protection) 
Enzyme: Throobin 
Buffer: 0.025 M Imidazole containing 0.025 M CaClt, 
0.01 S Carbowax 20M. pH 7.0 
Eluting buffer S Thrombin activity 
Initial buffer (unbound) 64 
0.2 M NaCl in buffer wash 
1.0 M NaCl in buffer wash n.d. 
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and Yonemitsu, 1971). The half life of TMOFB in water at pH 4 to 5 is 10 
minutes. This is sufficient time to selectively modify the free coo-
groups in proteins in aqueous conditions. 
Fibrinopeptide-A was modified with TMOFB as described in the 
Methods Section and was reacted with Affigel. In the procedure a 100-
fold excess of reagent was dissolved in to dry acetonitrile and then 
added slowly to the aqueous peptide solution. In order to achieve 
maximum efficiency, the pH was controlled between 4.5 and 5.5 using 0.5 
M NaOH. This modified fibrinopeptide-A was reacted with Affigel-15, as 
described previously. In case of ethanol amine protection, the 
modification is carried out after FPA was attached to the resin. This 
was not done in esterification because maximum concentration could be 
obtain in solution rather than in immobilized form on the resin during 
its reaction with TMOFB. The terminal arginine methyl ester was 
selectively hydrolyzed using thrombin or trypsin. The terminal arginine 
was removed by action of CPB and Arg-Sc was added using EDAC at pH 4.5 
where the esters are stable. The methyl ester protection of side chain 
coo- groups was removed at room temperature at pH 11.0. Table 16 shows 
thrombin binding of different modified forms of the resin during the 
synthesis of Affi-FPA-Argal using the methyl ester protection method. 
From the Table 16 it is evident that the resin prepared in this way 
lacks, a strong affinity towards thrombin. 
3. Enzymatic synthesis: The procedure utilized for the preparation 
of Affi-FPA-Argal using papain as reagent to form a peptide bond is 
outlined in Fig.~3. In this approach the Affi-desArg-FPA resin was 
Affi-Gel 15 + Fibrinopeptide-A 
CH~H/0.1 M NaHC03 (7 .5:2.5) 4°C, 1 hour 
Ethanolamine pH 8. 0 
Affi-Gel-FPA 
lCarboxypeptidase-B 0.1M NaHC03 40 min, room temperature 
Affi-Gel--des Arg-FPA 
1 Papain, pH-8.8 and 9.2 Arg-Sc 150 min, room temperature 
Affi-Gel-FPA-Arg-Sc 1 CHj>HICH§OOHIIICID (7: 1 :2) 
Affi-Gel-FPA-Argal 
Figur--e-24. Synthetic scheme utilized in the synthesis 
of a FPA-Argal liganded affinity resin. 
(Enzymatic method) 
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prepared as usual and the Arg-Sc added to the desarginine fibrinopeptide 
ligand using papain, as described by Mitin ~ ~ (1984). In this 
method, a low affinity between thrombin and Affi-FPA-Argal (Table 17) 
was observed. Qualitative test for presence of arginine showed very 
little arginine on the column by the the Sakaguchi test. 
4J. Separation of urokinase from thrombin on Affi-FPA-Argal column: 
Since both proteinases has different specificity, urokinase should 
not show an affinity towards Affi-FPA-Argal resins. Even though 
appreciable affinity was not observed in any of the preparations, the 
resin prepared without protecting side chain coo- groups (chemical 
method) showed some affinity towards thrombin. This preparation was 
utilized to try to separate urokinase and thrombin from a mixture. Table 
18 shows the activities of thrombin and urokinase in different fractions 
of elution of a 84 units of thrombin and 500 units of urokinase over 
Affi-FPA-Argal column. The procedure was same as described for the 
separation of two proteases over Affi-Phe-Pro-Argal column. The resin 
showed slightly greater affinity towards thrombin than to urokinase, but 
the difference is too small for practical purposes. 
Table 17 
Relative enzyme activities in 10 m1 fractions of column effluents. 
Resin: Affi-Gel-FPA-Argal (prepared by enzymatic method) 
Enzyme: Thrombin 
Buffer: 0.025 M Imidazole containing 0.025 M CaC12, 0.01 ~ Carbowax 20M. pH 7.0 
---------------------------------------------------
Eluting buffer J Thrombin activity 
Initial buffer (unbound) 20 
0.2 M NaCl in buffer wash 65 
1.0 M NaCl in buffer wash n.d. 
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Table 18 
Relative enzyme activities in 10 ml fractions of column effluents. 
Resin: Affi-Gel-FPA-Argal (prepared by chemical method) 
Enzyme: Mixture of Thrombin and Urokinase. 
Buffer: 0.025 H Lmidazole containing 0.025 H CaC12, 0.01 S Carbowax 20M. pH 7.0 
Eluting buffer 
Initial buffer (unbound) 
Additional 10 ml of 
initial buffer wash 
0.2 M NaCl in buffer wash 
S Enzyme activity 
Thrombin Urokinase 
17 62 
1 2 
55 
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CHAPTER V 
DISCUSSION 
~ Preparation Q( affinity resins 
1. Argal as ligand: Argal resins could be synthesized either by 
immobilization of arginine onto the resin followed by reduction of coo-
group of arginine to an aldehydic group or by reducing the arginine coo-
prior to immobilization. There are a number of technical difficulties in 
the first approach such as possible side reactions with the matrix and 
the physical separation of side products or solid reagent catalysts. The 
second approach appears technically more feasible and cleaner. It also 
allows characterization of ligand prior to its immobilizationan on the 
resin. 
Since the work was started in 1979, a number of new syntheses have 
been reported forO(-aminoaldehydes from amino acids and alcohols. The 
chemo selective reduction of acids to aldehydes (Fujisawa ~ ~. 1983) 
and the oxidation of N-protected)5-amino alcohols using a combination of 
sulfur trioxide-pyridine complex and DMSO in the presence of triethyl 
amine to optically active o(-amino aldehydes (Hamada and Shoiri, 1982) 
are good examples of new synthetic procedures. These techniques allow 
preparation of optically activeo(-amino aldehydes from most of the amino 
acids and the preparation of peptide aldehydes to be used as specific 
inhibitors. 
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' In this work preparation of affinity resin containingQ(-amino 
argininals as a ligands have been established. Possibilities still to be 
explored include the use of phenylalaninal as a ligand in affinity resin 
for the purification of proteases with chymotrypsin-like specificity. 
In preparation of affinity resins the spacer arm plays very 
important role in binding efficiency. When (Gly)n-Tyr-NH2 was used as 
ligand to bind chymotrypsin, the resin did not show affinity when n:O. 
The resin only showed affinity with n=3 or 4 (Blumberg and Katchalski-
Katzier, 1979). This type of steric effect of the resin in preventing 
association of the enzyme where the ligand is bound directly to the 
resin may be one of the reasons for the failure to of the Enzacryl-
Argininal resin to bind trypsin, as no spacer arm group was present. In 
addition to the length of the spacer arm, the ionic character of the 
spacer arm is also important. This is demonstrated by the increased 
efficiency of coupling of the negatively charged fibrinopeptide-A with 
Affigel-15 containing a positively charged spacer arm, with respect to 
its binding to the Affigel-10. 
The Sakaguchi test for guanidine group is convenient for 
qualitative and quantitative determinations of arginine. The extreme 
ease and speed of the test is useful in monitoring reactions involving 
guanidine group. During the removal of the N02 guanidine protection with 
hydrogenolysis it was important to remove the N02 protection and limit 
any undesirable reduction of the C:N Schiff's base double bond. The 
Sakaguchi test was necessary in monitoring this deprotection reaction. 
In addition to the guanidine group monitoring, aldehydic assays were 
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also crucial during hydrogenolysis. Preliminary work indicated that this 
could be easily accomplished spectrophotometrically using 
pararosaniline. Quantitation of aldehydic function on the resin may not 
be accurate because the reaction of p-phenyl azoaniline with aldehyde 
may not go to completion and its subsequent transfer to salicyl aldehyde 
might also fall short of complete reaction. This test establishes a 
minimum value for the presence of aldehydic group. Affi-Argal showed 
minimum of 0.1 ~m/ml of aldehyde by this test. Considering a 1:1 
stoichiometry between trypsin and Argal, the resin could bind 2.5 mg of 
trypsin per ml of resin. The theoretical capacity of the resin is 375 mg 
of trypsin per ml of resin based on 15pm/ml of resin. However, it is 
impossible to achieve this binding capacity due to steric reasons. At 
our minimal capacity of 2.5 mg trypsin/ml resin, 3 ml of column can 
purify significant quantities of protease in pure form. In comparison, a 
3 ml gel-filtration or ion-exchange column could only obtain a small 
amount of pure enzyme. 
5a Procedure fQr purification Q( serine QL cysteine proteases 
utilizing ~ ~ product Q( £ protease reaction 
A number of biological events are controlled by proteolytic action. 
In many instances the product of a biologically important proteolytic 
action is known and well characterized, but the protease itself has not 
been defined or characterized. For example during the induction of lytic 
growth of the Escherichia ~ prophage lambda, the C1-repressor protein 
is cleaved. The hydrolysis products of this reaction are well 
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characterized (Roberts and Devoret, 1983). Rec-A protein is belived to 
play an important role in this process. The proteolytic cleavage occurs 
between alanine and glycine in comparable positions of the four 
polypeptides of repressor protein. Affinity resins could be prepared for 
purification of the protease responsible for the proteolytic process in 
similar fashion as described for fibrinogen-thrombin reaction. This 
could be done by immobilizing repressor on a resin and cleaving the 
repressor with a cell lysate solution containing the protease, followed 
by the conversion of the newly formed COOH-terminal alanine to alaninal. 
A presupposition here is that the protease is a serine or cystine 
protease. 
The example of fibrinogen-thrombin is described in this work. 
Immobilization of neutral proteins or peptides do not present a major 
problem with most of the matrices, but highly basic or acidic proteins 
or peptides need a careful selection of the matrix or spacer arm. 
Immobilization of the highly acidic fibrinopeptide-A was very efficient 
with Affigel-15, which contains a positively charged spacer arm. With 
the Affigel-10, which contains a neutral spacer arm, appreciable 
coupling was obtained only after addition of ca+2 to the coupling 
solution. Monitoring the coupling reaction with Sakaguchi test provides 
· both qualitative and quantitative results. Since most proteins contain 
arginine, this test could be adopted for monitoring coupling reactions 
between proteins and matrix. Large proteins may not require a spacer arm 
for efficient binding, if the protease binding site in the protein 
substrate is reasonably far away from the matrix. 
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~ Modification Q( CQQH-terminal peptidyl amino ~tQ£n aldehydic 
function. 
In the biosynthesis of leupeptin, the leupeptin acid is reduced to 
leupeptin by leupeptin acid reductase (Umezawa and Aoyagi, 1983). This 
membrane bound enzyme could perhaps be used to reduce terminal coo-
groups. However, since the enzyme is membrane bound, it is difficult to 
use in in the laboratory preparation of Argininal. In addition it 
appears specific to the Leu-Leu-Arg sequence. The chemical approaches 
taken in this work for substituting the terminal amino acid by the 
corresponding amino aldehyde are more practical and general. 
The direct substitution of Arg-Sc using carboxypeptidase-B seemed 
to be a better alternate than to use carboxypeptidase-Y or other 
carboxypeptidases. Since the rate of removal of a terminal amino acid by 
carboxypeptidase-B is much higher for basic amino acids, there is a much 
higher probability of obtaining a homogeneous ligand. The penultimate 
amino acid in fibrinopeptide-A is valine and carboxypeptidase-B has a 
low activity towards valine. The use of carboxypeptidase-Y in trans 
peptidation reactions produced complex mixtures of products (Breddam ~ 
Ql., 1981). In addition to the carboxypeptidase activity, 
carboxypeptidase-Y has an amidase activity, which resulted in the 
subsequent formation of secondary products. 
Addition of organic co-solvents or change in pH or ionic strength 
of the buffer changes the equilibrium constant between hydrolysis and 
amidation. Addition of methanol or 1,4-butanediol to the reaction media 
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thus alters the equilibrium catalyzed by carboxypeptidase-B in favour of 
transpeptidation. 
The resin Affi-FPA-Argal produced by carboxypeptiase B with added 
Arg-Sc nucleophile in 1,4-butanediol showed some affinity towards 
thrombin. This affinity is not high enough to be useful, but the low 
activity could be solely due to a low total concentration of the 
desirable ligand, FPA-Argal. The DNP test on the resin showed the 
presence of very little aldehydic function. 
Affi-FPA-Argal resins prepared by chemical procedures showed a 
higher affinity towards thrombin (Tables 14,15). Although the pKa's of 
side chain coo- and terminal coo- groups are expected to be different, 
it is difficult to join Arg-Sc on just the terminal coo- selectively. 
This could be accomplished only by first blocking the side chain coo-
groups by methylation or with ethanolamine. Blocking the coo- sidechain 
groups by methylation results in decrease solubility of the protein, but 
since the reaction was carried out in 75% methanol, this appears not to 
pose a problem. 
After modification of all the free carboxyls by methylation, the 
terminal coo- was generated by the treatment with trypsin or thrombin, 
both enzymes serve the same purpose. In case of an unknown protease the 
biological solution containing the protease could be used to generate 
the terminal coo- group. 
To remove the terminal amino acid, carboxypeptidase proteases are 
an excellent reagents. An appropriate carboxypeptidase has to be 
selected for efficient removal of just the·terminal amino acid. The 
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time, concentration and temperature conditions need to be carefully 
worked out. In the cas~ of carboxypeptidase-a, the high selectivity for 
basic amino acids provides a very convenient method of selectively 
removing the terminal arginine. Also the reaction is easy to monitor 
with the Sakaguchi test. However, small residual amount of arginine 
remained on the resin, even after overnight treatment at 37 °C. The 
arginine remained perhaps because some arginine may not be accessible 
to CPB due to steric reasons. The work presented establishes the 
procedure to remove terminal arginine and also a method for monitoring 
the reaction is described. 
After addition of Arg-Sc to the des-Arginine <&(and ~-methyl)­
FPA, the removal of the methyl group protection of from the side chain 
coo- groups is important in order to restore the substrate to its 
natural form. Ethanolamine protection is not possible to selectively 
remove. The methyl esters are labile at basic conditions and treatment 
with sodium carbonate at pH 11 may be safe and effective for most 
protein substrates. Proteins and peptides can usualy survive this basic 
conditions for a short time without denaturation. 
Enzymatic synthesis, contrary to chemical synthesis, does nor 
require a special activation of the carboxyl group. Also a consequence 
of this specificity functional side groups of amino acids do not have to 
be protected. The additional advantages of enzymic synthesis are stereo 
specificity and milder reaction conditions. Since the penultimate amino 
acid in fibrinopeptide-A is valine, neither trypsin nor chymotrypsin 
have a primary specificity for the terminal amino acid and hence can not 
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be utilized as reagents. 
In thermolysin catalyzed peptide bond synthesis, the enzyme 
exhibits preference for a hydrophobic amino acid as the donor of the 
carboxyl group for the newly formed bond (Wayne and Fruton, 1983). The 
relative rate of the peptide bond synthesis with Z-Val-OH was observed 
to be 0.03 % compared to Z-Phe-OH. This indicates that thermolysin is 
not a good choice for formation of a Val-Arg-Sc bond. 
Papain has broad primary specificity towards substrates and 
therefore was selected as a possible reagent to form the Val-ArgSc bond. 
The kinetic approach described by Mitin ~ ~ (1984) was used at pH 
9.2. This pH value was selected to minimize hydrolysis of 
fibrinopeptide-A and to maximized formation of the peptide bond between 
desarginine fibrinopeptide-A and Arg-Sc. The peptidase activity of 
papain above pH 8.0 is negligible, but the synthesis activity at this pH 
is high. However, the Sakaguchi test on the resin Affi-FPA-Argal 
prepared by this method showed very little argininal present on the 
resin. In the pilot experiments by Mitin to establish the reaction 
conditions, protected amino acid methyl esters and dipeptide methyl 
esters were used(Mitin ~ ~ 1983). In addition, Mitin found the rate 
of synthesis is generally inversly proportional to the length of coo-
donating peptide. With respect to the amine component, dipeptides are 
better nucleophiles than mono amino acids or other small amines (Mitin 
~ ~ 1983; Bajkowski and Frankfater, 1983; Petkove and Stoineva, 
1984). DesargFPA is 15 amino acids long and therefore the rate of 
synthesis may be expected to be slow, and the nucleophile Arg-Sc is 
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only a mono amino acid making it disadvantageous from both sides. 
Among all the three different approaches to substitute ArgSc for 
arginine in Affi-FPA, the chemical synthetic approach showed some 
success, with a minimum of 66% removal of terminal arginine by CPB 
followed by high degree of addition of Arg-Sc to the desArg ligand. The 
total concentration of the FPA on the resin is 0.6 nanamoles/ml, and 
after chemical modification, the concentration of FPA-Argal could be as 
much as 0.4 nanamoles/ml. This is a low concentration compare to 
tripeptide aldehyde resins (0.1 to 0.21 micromoles). It translates into 
a capacity of 0.034 mg (75 units) of total thrombin binding capacity. 
This capacity of the resin could be increase by increasing the ligand 
concentration. 
Nishikata ~ ~ (1981) and Ishii and Kasai (1981) have previously 
reported the preparation of Leu-Argal and Gly-Gly-Argal affinity resins 
for purification of Streptomyces grieses trypsin and bovine trypsin. In 
their work, strong acid was used to decomposed a semicarbazone 
derivatized resin to free aldehyde and either strong acid (50 mM HCl) or 
1x1o-4 M leupeptin was used to elute the tightly bound trypsins from the 
resins. In the leupeptin containing buffers, the dissociated enzyme is 
eluted as an inhibited complex with the leupeptin inhibitor. The 
leupeptin then needs to be dialyzed or destroyed by NaBH4 reduction 
before the appearance of catalytic activity in the eluted fractions. 
In this work, it was found that treatment of our resins with a 
strong acid was destructive of the trypsin binding properties to the 
resin. However, the removal of the semicarbazone protection in acetic 
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acid/methanol/formaldehyde, as described, was found to be non-
destructive as repeated treatments with this reagent did not have any 
detrimental effect on proteinase affinity. Furthermore, the removal of 
tightly bound proteases with semicarbazide containing buffers rather 
than buffer containing proteinase inhibitors has the advantage of not 
requiring additional steps before the generation of a catalytic activity 
in the eluted enzyme fractions. Nonspecific adsorption of enzyme on the 
resin and the glassware was prevented by including a surfactant, 
carbowax-20M, in the buffer. 
5D Association Q[ proteases tQ affinity resins. 
As argued in Chapter 2, the the peptidyl aldehyde ligands associate 
serine proteases by forming a reversible covalent hemiacetal with the 
active site serine, as shown in Fig.2, where E-OH is the active site 
serine o-OH of the enzyme and RCH:O the peptidyl aldehyde. The rate of 
hemiacetal formation has been shown in the serine proteinase 
chymotrypsin to be general base-specific acid-catalyzed, as depicted in 
Fig.2 (Kennedy and Schultz, 1977) and the hemiacetal (IIB in Fig.2) has 
a similarity to the tetrahedral intermediate and/or transition state 
formed during substrate catalysis (Kennedy and Schultz, 1977; Thompson, 
1973; Chen ~ ~ 1979; Thompson and Bauer, 1979). The free energy for 
aldehyde association is much greater in the enzyme active site 
(approximatly 2.8 to 3.0 Kcal/mole) for aldehydes with a specific P1 
side chain than for their amide substrate analogs (Thompson and Bauer, 
1979). Based on this value, peptide aldehyde will associate about 1000 
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fold strongly to the enzyme than the same peptide without the aldehydic 
group. From X-ray crystallography, non-covalent complexes between serine 
proteases and specific ligands are characterized by low internal 
mobility, and covalent reactions within these complexes should therefore 
occur with abnormally favourable entropies of reaction (James ~ ~ 
1980). In the case of a protease catalyzed substrate hydrolysis, the 
transition-state is a high energy ester with a pyramidal carbonyl carbon 
atom and with the carbonyl oxygen remaining in the strongly polarizing 
electrostatic field of the oxyanion hole. Contrary to this, in case of 
peptide aldehydes, the hemiacetal is a low energy complex with a 
protonated oxygen in the oxanion hole (productive mode in Fig 6) or the 
aldehydic c1 hydrogen in the oxyanion hole (non-productive mode in Fig 
6). 
The high affinity of the aldehyde ligands to serine proteases is 
supported by the affinity of the Affi-Argal resin to trypsin, which 
is significantly greater than to an affinity resin in which trypsin is 
associated non-covalently. This is shown by the ability to elute trypsin 
from the non-covalent affinity resins such as lysine or benzamidine 
liganded resins by high salt and/or low pH, where as the Affi-Argal 
resin binds trypsin irreversibly under these conditions. In addition to 
the aldehydic function, the importance of side chain interactions is 
clearly demonstrated by the preferential affinity to trypsin over 
chymotrypsin, which clearly shows that the guanidinium group is also 
required for the selectivity and specificity of binding. 
The Affi-Argal resin serves as a model for the preparation of 
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highly effective affinity resins using specific peptidyl aldehyde 
ligands. The tighter binding to the Argal ligand than to non-covalent 
binding resins show that the Argal resin can be used for the affinity 
purification or inhibition of proteases at low protease concentrations. 
In addition, as peptidyl aldehydes do not show any significant pH 
dependency between pH 3 and 8 for association of proteases, affinity 
purification of proteases can be carried out at pH<7.0 at which pH 
values most proteases are catalytically inactive and, thus, 
autocatalytic degradation will not be of consequence. 
By keeping Argal in the terminal position and extending the ligand 
towards the N-terminal, the specificity of the ligand was increased to 
discriminate between proteases in the same class. The combination of 
secondary specificity with the aldehydic function makes these ligands 
highly specific and potent inhibitors. Thus, the peptide aldehyde D-Phe-
Pro-Argal has shown to have a binding constant towards thrombin of 
between 4.5x1o-7 and 7.5x10-8M (Bajusz ~ ~ 1978; Fareed ~ 
~1981). As peptide argininals in water are in equilibrium with its 
aldehyde hydrate and with a tautomeric carbinolamine structure formed by 
the reversible addition of the guanidine nitrogen to the aldehyde 
function, the concentration of free aldehyde available to participate in 
the equilibrium with the enzyme has been shown by NMR to be 1% of the 
total concentration of the peptide in aqueous solution (Kozlowski and 
Schultz, unpublished results). Accordingly, based on the concentration 
of free aldehyde, the true Ki for the binding of D-Phe-Pro-Argal is in 
the range of 1o-11M. The binding constant to L-Phe-Pro-Argal is 
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estimated to be 100 fold poorer than for D-Phe-Pro-Argal to thrombin 
(Bajusz ~ ~1978). Thus, the corrected binding constant to the Phe-
Pro-Argal ligands in Affi-Phe-Pro-Argal can be estimated to be near 10-8 
to 1o-1° M. Similarly the estimated binding constant of Affi-Gly-Gly-
Argal is expected to be near 10-7 to 10-8 M (Ahsan, Pagast and Schultz, 
unpublished results). These low values of Ki for the binding of specific 
peptidyl argininals to proteinases approach those binding constants 
observed between an antibody and an antigen. Even lower values of Ki 
than to the serine proteinases can be calculated for peptidyl aldehyde 
binding to cysteine proteases (Westerick and Wolfenden, 1972; Frankfater 
and Kuppy, 1981). Accordingly, the peptidyl aldehyde liganded resins 
will have an extremely high affinity to both serine and cysteine 
proteases and can potentially be utilized to purify proteinases present 
in very low concentrations in biological fluids. 
The ability to bind a particular proteinase by variation of X-Y 
represents an amplification of normal peptide binding specificity 
similar to that previously observed for peptide aldehyde inhibitors of 
chymotrypsin, elastase and papain (Thompson, 1973; Kennedy and Schultz, 
1979; Thompson and Bauer,1979; Wolfenden, 1972). For example, in the 
case of chymotrypsin, an increased affinity of approximately 140-fold 
can be calculated for the binding of the specific aldehyde Bz-L-Pheal 
over that of the non-specific aldehyde hydrocinnamaldehyde (after 
correction for hydration), whereas the respective Ks values for the 
substrates Bz-L-Phe-NH2 and hydrocinnamide differ by a factor of only 
two (Kennedy and Schultz, 1979; Schultz and Cheerva, 1975). This 
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amplification of normal differences in binding affinities for specific 
aldehyde ligands over non or less-specific aldehyde ligands is due to an 
increse in the ratio of k2/k_2 in fig-2, and may reflect the greater 
complementarity of the more specific analog to the transition state 
configuration of the enzyme. 
I had a limited success with fibrinopeptide Argininal resins. The 
tighter binding was observed in a case in which overnight reaction with 
carboxypeptidase-B was carried out to prepare desArg-FPA on the resin. 
In this case the exact nature of the ligand is unknown, but irreversible 
binding was observed. In other preparations, where the nature of ligand 
could be predicted to be FPA-Argal with a certain certainty, the 
affinity is poor for thrombin. In our prediction of a high affinity for 
the ligand, we are assuming that the conformation of product (P2) is 
retained, as in the parent protein molecule, even after proteolytic 
cleavage and also after its immobilization on the matrix. Pentamer to 
decamer peptides form inter molecular)3-structure in the solid state and 
in some solvents; and an eicosapeptide exhibits a high percentage of (7(-
helical structure both in the solid state and in solution (Toniolo et 
al, 1984). X-ray analysis of a linear hexa and octa peptides suggests 
formation of a hairpin shaped conformation stabilized by multiple intra-
molecular H-bonds (Bavaso ~ ~ 1982; Lagant ~ ~ 1984). However 
the immobilized fibrinopeptide-A-Argal may assume a stable conformation 
which could be different from fibrinopeptide-A portion of fibrinogen. In 
addition after proteolytic cleavage, conformation changes often occur in 
the protein around the proteolytic cleavage site. For example, a 
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monoclonal antibody study shows that the amino terminus of theA~chain 
in human fibrin exhibits a different conformation than in human 
fibrinogen (Hui and Haber, 1983). If the proteolytic cleavage occurs 
between two domains of a large protein the conformational change may not 
be drastic. Thus the example of fibrinopeptide-A-thrombin could be a 
poor choice to demonstrate the idea of a general procedure to prepare 
affinity resins using aldehyde transition state analog. Other cases,such 
as the plasminogen-plasminogen activator system, might prove to be more 
successful. 
As many trypsin-like proteinases often coexist in a particular 
biological compartment or pathway (Reich ~ ~ 1975), it is of 
importance to be able to separate a particular trypsin-like proteinase 
from other proteinases of similar primary binding site specificity for 
arginine or lysine. This work shows the ability of the R-(X-Y-Argal) 
resins to separate a particular serine proteinases (thrombin or 
urokinase) from a solution containing a mixture of two proteinases of 
identical primary binding specificity for arginine. Accordingly, from an 
£ prioi knowledge of an arginine specific proteinase's secondary binding 
site specificity, a R-X-Y-Argal sequence can be designed to selectively 
separate a proteinase of interest. 
SUMMARY 
The purification of proteolytic enzymes from biological systems is 
often difficult, especially when the concentration of the enzyme is low 
and multiple enzymes with an identical primary specificity are present. 
One of the more promising techniques for protease purification is 
affinity chromatography. I have synthesized a new family of affinity 
chromatography ligands consisting of peptides containing the aldehyde 
analog of arginine in the C-terminal position. Upon association with the 
serine protease, such peptide aldehydes mimic features of the 
transition-state configuration of substrates during hydrolysis and hence 
will be expected to associate with extremly high affinity and 
specificity as predicted for transition-state analogs. 
The aldehyde analog of arginine was synthesized by reduction of 
Cbz-N02-Arginine with LiAlH4 in tetrahydrofuran in presence of 1,1'-
carbonyldiimidazole at -70 °C. The aldehydic function was protected by 
forming a semicarbazone derivative, which served as a stable 
intermediate. Cbz and N02 protections were removed by catalytic 
hydrogenation in the presence of palladium black. Arginine semicarbazone 
was immobilized on Affi-Gel-10 through a stable amide bond. The resin 
showed extremly high affinity toward trypsin and no affinity towards 
chymotrypsin. The trypsin activity remained bound to the resin even 
after exhaustive washing. 
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To exploit secondary specificity of proteases, affinity resins of 
the general formula R-X-Y-Arginal (where R- is resin matrix and -X-Y- is 
a dipeptide) were synthesized. The tripeptide synthesis on the resin was 
N-terminal to C-terminal, which is opposite from the commonly utilized 
Marrifield solid phase peptide synthesis. The conditions for binding and 
elution from Affi-X-Y-Arginal resins (-X-Y- = Phe-Pro, Phe-Ala and Gly-
Gly) of the serine proteases trypsin, thrombin and urokinase are 
described in this work. In all cases in which the peptidyl argininal 
showed a high specificity to a particular protease (i.e., Gly-Gly-
Arginal for urokinase and Phe-Pro-Arginal for thrombin), the protease 
could not be removed with high ionic strength buffers. Urokinase and 
thrombin could be separated from one another and purified by either an 
Affi-Phe-Pro-Arginal or an Affi-Gly-Gly Arginal affinity column. A 
method to elute the tightly bound proteases in an active form was 
established using 0.1 M semicarbazide containing 0.1 M sodium acetate, 
0.025 M Cac12 and 0.01 % Carbowax 20M. The resin could be regenerated 
repeatedly without loss of its protease binding capacity by overnight 
treatment with methanol/ acetic acid/ formaldehyde.The concentration of 
Arginine aldehyde was determined by p-aminoazoaniline and salicyaldehyde 
system and showed a minimum of 0.1 micromole/ ml of resin. Based on this 
value, the protease binding capacity of the resin is 2.5 mg of trypsin-
like protease/ ml of resin. 
A general procedure for purification of proteases in which acid 
product of a specific substrate of the the protease is attached by its 
N-terminal residue to an inert support and the COOH-terminal amino acid 
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modified to a peptide aldehyde to generate the transition-state analog 
inhibitor of the protease of interest is descried. A particular case of 
fibrinopeptide-A to purify thrombin was investigated with limited 
success, perhaps due to very low concentration of the ligand on the 
affinity resin. Three different approaches to substitute the terminal 
arginine in fibrinopeptide-A by Arginine semicarbazone were investigated 
including (i) direct substitution, (ii) chemical method and (iii) 
enzymatic method. 
These transition-state affinity purification technique should have 
a general usefulness in the isolation and purification of biologically 
important proteases for therapeutic use in coagulation disorders. 
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